RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy12508
         (113 letters)



>gnl|CDD|198198 cd09945, SH2_SHB_SHD_SHE_SHF_like, Src homology 2 domain found in
           SH2 domain-containing adapter proteins B, D, E, and F
           (SHB, SHD, SHE, SHF).  SHB, SHD, SHE, and SHF are SH2
           domain-containing proteins that play various roles
           throughout the cell.  SHB functions in generating
           signaling compounds in response to tyrosine kinase
           activation. SHB contains proline-rich motifs, a
           phosphotyrosine binding (PTB) domain, tyrosine
           phosphorylation sites, and a SH2 domain. SHB mediates
           certain aspects of platelet-derived growth factor (PDGF)
           receptor-, fibroblast growth factor (FGF) receptor-,
           neural growth factor (NGF) receptor TRKA-, T cell
           receptor-, interleukin-2 (IL-2) receptor- and focal
           adhesion kinase- (FAK) signaling. SRC-like FYN-Related
           Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB
           regulate apoptosis, proliferation and differentiation.
           SHB promotes apoptosis and is also required for proper
           mitogenicity, spreading and tubular morphogenesis in
           endothelial cells. SHB also plays a role in preventing
           early cavitation of embryoid bodies and reduces
           differentiation to cells expressing albumin, amylase,
           insulin and glucagon. SHB is a multifunctional protein
           that has difference responses in different cells under
           various conditions. SHE is expressed in heart, lung,
           brain, and skeletal muscle, while expression of SHD is
           restricted to the brain. SHF is mainly expressed in
           skeletal muscle, brain, liver, prostate, testis, ovary,
           small intestine, and colon. SHD may be a physiological
           substrate of c-Abl and may function as an adapter
           protein in the central nervous system. It is also
           thought to be involved in apoptotic regulation.  SHD
           contains five YXXP motifs, a substrate sequence
           preferred by Abl tyrosine kinases, in addition to a
           poly-proline rich region and a C-terminal SH2 domain.
           SHE contains two pTry protein binding domains, protein
           interaction domain (PID) and a SH2 domain, followed by a
           glycine-proline rich region, all of which are N-terminal
           to the phosphotyrosine binding (PTB) domain. SHF
           contains  four putative tyrosine phosphorylation sites
           and an SH2 domain. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 98

 Score =  162 bits (413), Expect = 9e-54
 Identities = 66/97 (68%), Positives = 85/97 (87%), Gaps = 1/97 (1%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           WYHG++TR EAE++LR   EGSYLVRNSES + DYSLSLKSA+GFMHM+IQR+ +TG++I
Sbjct: 3   WYHGAITRIEAESLLRPCKEGSYLVRNSESTKQDYSLSLKSAKGFMHMRIQRN-ETGQYI 61

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPM 108
           LGQFS PF+++PEMI+H+  N+LP+ GAEHMCLL P+
Sbjct: 62  LGQFSRPFETIPEMIRHYCLNKLPVRGAEHMCLLEPV 98


>gnl|CDD|198255 cd10392, SH2_SHF, Src homology 2 domain found in SH2
           domain-containing adapter protein F (SHF).  SHF is
           thought to play a role in PDGF-receptor signaling and
           regulation of apoptosis. SHF is mainly expressed in
           skeletal muscle, brain, liver, prostate, testis, ovary,
           small intestine, and colon. SHF contains  four putative
           tyrosine phosphorylation sites and an SH2 domain. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 98

 Score =  128 bits (322), Expect = 4e-40
 Identities = 58/97 (59%), Positives = 78/97 (80%), Gaps = 1/97 (1%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           WYHG+++R +AEN+LR   E SYLVRNSE+++ D+SLSLKS++GFMHMK+ R  +  K++
Sbjct: 3   WYHGAISRTDAENLLRLCKEASYLVRNSETSKNDFSLSLKSSQGFMHMKLSRTKEH-KYV 61

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPM 108
           LGQ S PF SVPE+I H+A  +LPI GAEHM LL+P+
Sbjct: 62  LGQNSPPFSSVPEIIHHYASRKLPIKGAEHMSLLYPV 98


>gnl|CDD|198252 cd10389, SH2_SHB, Src homology 2 domain found in SH2
           domain-containing adapter protein B (SHB).  SHB
           functions in generating signaling compounds in response
           to tyrosine kinase activation. SHB contains proline-rich
           motifs, a phosphotyrosine binding (PTB) domain, tyrosine
           phosphorylation sites, and a SH2 domain. SHB mediates
           certain aspects of platelet-derived growth factor (PDGF)
           receptor-, fibroblast growth factor (FGF) receptor-,
           neural growth factor (NGF) receptor TRKA-, T cell
           receptor-, interleukin-2 (IL-2) receptor- and focal
           adhesion kinase- (FAK) signaling. SRC-like FYN-Related
           Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB
           regulate apoptosis, proliferation and differentiation.
           SHB promotes apoptosis and is also required for proper
           mitogenicity, spreading and tubular morphogenesis in
           endothelial cells. SHB also plays a role in preventing
           early cavitation of embryoid bodies and reduces
           differentiation to cells expressing albumin, amylase,
           insulin and glucagon. SHB is a multifunctional protein
           that has difference responses in different cells under
           various conditions. In general SH2 domains are involved
           in signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score =  118 bits (297), Expect = 3e-36
 Identities = 55/97 (56%), Positives = 77/97 (79%), Gaps = 2/97 (2%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           WYHG+++R +AEN+LR   E SYLVRNS++++ DYSLSLKS +GFMHMK+ +  +  K++
Sbjct: 3   WYHGAISRGDAENLLRLCKECSYLVRNSQTSKHDYSLSLKSNQGFMHMKLAKTKE--KYV 60

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPM 108
           LGQ S PFDSVPE+I ++   +LPI GAEH+ LL+P+
Sbjct: 61  LGQNSPPFDSVPEVIHYYTTRKLPIKGAEHLSLLYPV 97


>gnl|CDD|198254 cd10391, SH2_SHE, Src homology 2 domain found in SH2
           domain-containing adapter protein E (SHE).  SHE is
           expressed in heart, lung, brain, and skeletal muscle.
           SHE contains two pTry protein binding domains, protein
           interaction domain (PID) and a SH2 domain, followed by a
           glycine-proline rich region, all of which are N-terminal
           to the phosphotyrosine binding (PTB) domain. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 98

 Score =  108 bits (272), Expect = 2e-32
 Identities = 48/97 (49%), Positives = 70/97 (72%), Gaps = 1/97 (1%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           WYHGS++R EAE+ L+   E SYLVRNSES    YS++LK+++G +H+ + +  D  K+ 
Sbjct: 3   WYHGSISRAEAESRLQPCKEASYLVRNSESGNSKYSIALKTSQGCVHIIVAQTKDN-KYT 61

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPM 108
           L Q SA FDS+PE++ +++  +LP  GAEHM LLHP+
Sbjct: 62  LNQTSAVFDSIPEVVHYYSNEKLPFKGAEHMTLLHPV 98


>gnl|CDD|198253 cd10390, SH2_SHD, Src homology 2 domain found in SH2
           domain-containing adapter proteins D (SHD).  The
           expression of SHD is restricted to the brain. SHD may be
           a physiological substrate of c-Abl and may function as
           an adapter protein in the central nervous system. It is
           also thought to be involved in apoptotic regulation. SHD
           contains five YXXP motifs, a substrate sequence
           preferred by Abl tyrosine kinases, in addition to a
           poly-proline rich region and a C-terminal SH2 domain. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 98

 Score =  102 bits (256), Expect = 6e-30
 Identities = 48/97 (49%), Positives = 70/97 (72%), Gaps = 1/97 (1%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           W+HG ++R +AEN+L    EGSYLVR SE+   D SLSL+S++GF+H+K  R  +  + +
Sbjct: 3   WFHGPLSRADAENLLSLCKEGSYLVRLSETRPQDCSLSLRSSQGFLHLKFARTREN-QVV 61

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPM 108
           LGQ S PF SVPE++ H++   LP+ GAEH+ LL+P+
Sbjct: 62  LGQHSGPFPSVPELVLHYSSRPLPVQGAEHLALLYPV 98


>gnl|CDD|214585 smart00252, SH2, Src homology 2 domains.  Src homology 2 domains
          bind phosphotyrosine-containing polypeptides via 2
          surface pockets. Specificity is provided via
          interaction with residues that are distinct from the
          phosphotyrosine. Only a single occurrence of a SH2
          domain has been found in S. cerevisiae.
          Length = 84

 Score = 88.8 bits (221), Expect = 1e-24
 Identities = 32/85 (37%), Positives = 53/85 (62%), Gaps = 2/85 (2%)

Query: 11 NWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
           WYHG ++R EAE +L+N  +G +LVR+SES+  DY LS++      H +I+R+ D   +
Sbjct: 2  PWYHGFISREEAEKLLKNEGDGDFLVRDSESSPGDYVLSVRVKGKVKHYRIRRNEDGKFY 61

Query: 71 ILGQFSAPFDSVPEMIQHFAENRLP 95
          + G     F S+ E+++H+ +N L 
Sbjct: 62 LEGGRK--FPSLVELVEHYQKNSLG 84


>gnl|CDD|198173 cd00173, SH2, Src homology 2 (SH2) domain.  In general, SH2
          domains are involved in signal transduction; they bind
          pTyr-containing polypeptide ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites. They are present in a
          wide array of proteins including: adaptor proteins
          (Nck1, Crk, Grb2), scaffolds (Slp76, Shc, Dapp1),
          kinases (Src, Syk, Fps, Tec), phosphatases (Shp-1,
          Shp-2), transcription factors (STAT1),  Ras signaling
          molecules (Ras-Gap), ubiquitination factors (c-Cbl),
          cytoskeleton regulators (Tensin), signal regulators
          (SAP), and phospholipid second messengers (PLCgamma),
          amongst others.
          Length = 79

 Score = 86.4 bits (214), Expect = 1e-23
 Identities = 33/79 (41%), Positives = 51/79 (64%), Gaps = 2/79 (2%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARG-FMHMKIQRDPDTGKF 70
          W+HGS++R EAE +LR   +G++LVR S S   DY LS++S  G   H  I+R+   G +
Sbjct: 2  WFHGSISREEAERLLRGKPDGTFLVRESSSEPGDYVLSVRSGDGKVKHYLIERNEG-GYY 60

Query: 71 ILGQFSAPFDSVPEMIQHF 89
          +LG     F S+PE+++H+
Sbjct: 61 LLGGSGRTFPSLPELVEHY 79


>gnl|CDD|215658 pfam00017, SH2, SH2 domain. 
          Length = 77

 Score = 82.2 bits (204), Expect = 4e-22
 Identities = 32/79 (40%), Positives = 50/79 (63%), Gaps = 3/79 (3%)

Query: 12 WYHGSVTRHEAENILRNSN-EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
          WYHG ++R EAE +L N   +G++LVR SES   DY+LS++      H +IQ   + G +
Sbjct: 1  WYHGKISREEAERLLLNPKPDGTFLVRESESKPGDYTLSVRDDGRVKHYRIQSLDNGGYY 60

Query: 71 ILGQFSAPFDSVPEMIQHF 89
          I G     F+S+PE+++H+
Sbjct: 61 ISG--GVTFNSLPELVEHY 77


>gnl|CDD|198183 cd09929, SH2_BLNK_SLP-76, Src homology 2 (SH2) domain found in
           B-cell linker (BLNK) protein and SH2 domain-containing
           leukocyte protein of 76 kDa (SLP-76).  BLNK (also known
           as SLP-65 or BASH) is an important adaptor protein
           expressed in B-lineage cells. BLNK consists of a
           N-terminal sterile alpha motif (SAM) domain and a
           C-terminal SH2 domain.  BLNK is a cytoplasmic protein,
           but a part of it is bound to the plasma membrane through
           an N-terminal leucine zipper motif and transiently bound
           to a cytoplasmic domain of Iga through its C-terminal
           SH2 domain upon B cell antigen receptor
           (BCR)-stimulation. A non-ITAM phosphotyrosine in Iga is
           necessary for the binding with the BLNK SH2 domain
           and/or for normal BLNK function in signaling and B cell
           activation. Upon phosphorylation BLNK binds Btk and
           PLCgamma2 through their SH2 domains and mediates
           PLCgamma2 activation by Btk. BLNK also binds other
           signaling molecules such as Vav, Grb2, Syk, and HPK1.
           BLNK has been shown to be necessary for BCR-mediated
           Ca2+ mobilization, for the activation of
           mitogen-activated protein kinases such as ERK, JNK, and
           p38 in a chicken B cell line DT40, and for activation of
           transcription factors such as NF-AT and NF-kappaB in
           human or mouse B cells. BLNK is involved in B cell
           development, B cell survival, activation, proliferation,
           and T-independent immune responses. BLNK is structurally
           homologous to SLP-76. SLP-76 and (linker for activation
           of T cells) LAT are adaptor/linker proteins in T cell
           antigen receptor activation and T cell development. BLNK
           interacts with many downstream signaling proteins that
           interact directly with both SLP-76 and  LAT.  New data
           suggest functional complementation of SLP-76 and LAT in
           T cell antigen receptor function with BLNK in BCR
           function. In general SH2 domains are involved in signal
           transduction.  They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 121

 Score = 68.9 bits (169), Expect = 2e-16
 Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 13/119 (10%)

Query: 1   MANPKPLDQRNWYHGSVTRHEAENILRNSN-EGSYLVRNS---ESNRPDYSLSLKSARGF 56
                 L  + WY G++ R EAE  LR SN +G++LVR+S   +S++P Y+L +      
Sbjct: 2   AEEEADLLPKEWYAGNIDRKEAEEALRRSNKDGTFLVRDSSGKDSSQP-YTLMVLYNDKV 60

Query: 57  MHMKIQRDPDTGKFILG---QFSAPFDSVPEMIQHFAENRLPIL-----GAEHMCLLHP 107
            +++I+   +T ++ LG   +    F SV E+I+H  +  L ++       +  CLL+ 
Sbjct: 61  YNIQIRFLENTRQYALGTGLRGEETFSSVAEIIEHHQKTPLLLIDGKDNTKDSTCLLYA 119


>gnl|CDD|198272 cd10409, SH2_Nck2, Src homology 2 (SH2) domain found in Nck.  Nck
           proteins are adaptors that modulate actin cytoskeleton
           dynamics by linking proline-rich effector molecules to
           tyrosine kinases or phosphorylated signaling
           intermediates.  There are two members known in this
           family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth
           factor receptor-bound protein 4 (Grb4)).  They are
           characterized by having 3 SH3 domains and a C-terminal
           SH2 domain. Nck1 and Nck2 have overlapping functions as
           determined by gene knockouts. Both bind receptor
           tyrosine kinases and other tyrosine-phosphorylated
           proteins through their SH2 domains. In addition they
           also bind distinct targets.  Neuronal signaling
           proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all
           bind to Nck-2 exclusively. And in the case of PDGFR,
           Tyr(P)751 binds to  Nck1 while Tyr(P)1009 binds to Nck2.
           Nck1 and Nck2 have a role in the infection process of
           enteropathogenic Escherichia coli (EPEC). Their SH3
           domains are involved in recruiting and activating the
           N-WASP/Arp2/3 complex inducing actin polymerization
           resulting in the production of pedestals, dynamic
           bacteria-presenting protrusions of the plasma membrane.
           A similar thing occurs in the vaccinia virus where
           motile plasma membrane projections are formed beneath
           the virus.  Recently it has been shown that the SH2
           domains of both Nck1 and Nck2 bind the G-protein coupled
           receptor kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 98

 Score = 65.4 bits (159), Expect = 3e-15
 Identities = 35/93 (37%), Positives = 57/93 (61%), Gaps = 7/93 (7%)

Query: 10  RNWYHGSVTRHEAENILRNSN-EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTG 68
           + WY+G+VTRH+AE  L     EG +L+R+SES+  D+S+SLK+     H K+Q      
Sbjct: 1   KEWYYGNVTRHQAECALNERGVEGDFLIRDSESSPSDFSVSLKAVGKNKHFKVQL--VDN 58

Query: 69  KFILGQFSAPFDSVPEMIQHFAENRLPILGAEH 101
            + +GQ    F+S+ E+++H+   + PI  +EH
Sbjct: 59  VYCIGQ--RRFNSMDELVEHY--KKAPIFTSEH 87


>gnl|CDD|198193 cd09940, SH2_Vav_family, Src homology 2 (SH2) domain found in the
          Vav family.  Vav proteins are involved in several
          processes that require cytoskeletal reorganization,
          such as the formation of the immunological synapse
          (IS), phagocytosis, platelet aggregation, spreading,
          and transformation.  Vavs function as guanine
          nucleotide exchange factors (GEFs) for the Rho/Rac
          family of GTPases.  Vav family members have several
          conserved motifs/domains including: a leucine-rich
          region, a leucine-zipper, a calponin homology (CH)
          domain, an acidic domain, a Dbl-homology (DH) domain, a
          pleckstrin homology (PH) domain, a cysteine-rich
          domain, 2 SH3 domains,  a proline-rich region, and a
          SH2 domain.  Vavs are the only known Rho GEFs that have
          both the DH/PH motifs and SH2/SH3 domains in the same
          protein. The leucine-rich helix-loop-helix (HLH) domain
          is thought to be involved in protein heterodimerization
          with other HLH proteins and it may function as a
          negative regulator by forming inactive heterodimers.
          The CH domain  is usually involved in the association
          with filamentous actin, but in Vav it controls NFAT
          stimulation, Ca2+ mobilization, and its transforming
          activity. Acidic domains are involved in
          protein-protein interactions and contain regulatory
          tyrosines. The DH domain is a GDP-GTP exchange factor
          on Rho/Rac GTPases. The PH domain in involved in
          interactions with GTP-binding proteins, lipids and/or
          phosphorylated serine/threonine residues. The SH3
          domain is involved in localization of proteins to
          specific sites within the cell interacting with protein
          with proline-rich sequences.  The SH2 domain mediates a
          high affinity interaction with tyrosine phosphorylated
          proteins.  There are three Vav mammalian family
          members: Vav1 which is expressed in the hematopoietic
          system, Vav2 and Vav3 are more ubiquitously expressed.
          The members here include insect and amphibian Vavs. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 102

 Score = 64.2 bits (157), Expect = 7e-15
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 2/84 (2%)

Query: 11 NWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
           W+ G + R  AEN L N  +G+YLVR        Y+LS+K      HMKI++  D G +
Sbjct: 6  LWFVGEMERDTAENRLENRPDGTYLVRVRPQGETQYALSIKYNGDVKHMKIEQRSD-GLY 64

Query: 71 ILGQFSAPFDSVPEMIQHFAENRL 94
           L + S  F S+ E++ ++  N L
Sbjct: 65 YLSE-SRHFKSLVELVNYYERNSL 87


>gnl|CDD|198196 cd09943, SH2_Nck_family, Src homology 2 (SH2) domain found in the
           Nck family.  Nck proteins are adaptors that modulate
           actin cytoskeleton dynamics by linking proline-rich
           effector molecules to tyrosine kinases or phosphorylated
           signaling intermediates. There are two members known in
           this family: Nck1 (Nckalpha) and Nck2 (Nckbeta and
           Growth factor receptor-bound protein 4 (Grb4)).  They
           are characterized by having 3 SH3 domains and a
           C-terminal SH2 domain. Nck1 and Nck2 have overlapping
           functions as determined by gene knockouts. Both bind
           receptor tyrosine kinases and other
           tyrosine-phosphorylated proteins through their SH2
           domains. In addition they also bind distinct targets.
           Neuronal signaling proteins: EphrinB1, EphrinB2, and
           Disabled-1 (Dab-1) all bind to Nck-2 exclusively. And in
           the case of PDGFR, Tyr(P)751 binds to  Nck1 while
           Tyr(P)1009 binds to Nck2. Nck1 and Nck2 have a role in
           the infection process of enteropathogenic Escherichia
           coli (EPEC). Their SH3 domains are involved in
           recruiting and activating the N-WASP/Arp2/3 complex
           inducing actin polymerization resulting in the
           production of pedestals, dynamic bacteria-presenting
           protrusions of the plasma membrane. A similar thing
           occurs in the vaccinia virus where motile plasma
           membrane projections are formed beneath the virus.
           Recently it has been shown that the SH2 domains of both
           Nck1 and Nck2 bind the G-protein coupled receptor
           kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 93

 Score = 62.9 bits (153), Expect = 2e-14
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 7/91 (7%)

Query: 12  WYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
           WY+G +TRH+AE +L  + +EG +L+R+SESN  DYS+SLK+     H K+Q       +
Sbjct: 3   WYYGRITRHQAETLLNEHGHEGDFLIRDSESNPGDYSVSLKAPGRNKHFKVQV--VDNVY 60

Query: 71  ILGQFSAPFDSVPEMIQHFAENRLPILGAEH 101
            +GQ    F ++ E+++H+   + PI  +E 
Sbjct: 61  CIGQRK--FHTMDELVEHY--KKAPIFTSEQ 87


>gnl|CDD|199828 cd09941, SH2_Grb2_like, Src homology 2 domain found in Growth
          factor receptor-bound protein 2 (Grb2) and similar
          proteins.  The adaptor proteins here include homologs
          Grb2 in humans, Sex muscle abnormal protein 5 (Sem-5)
          in Caenorhabditis elegans, and Downstream of receptor
          kinase (drk) in Drosophila melanogaster. They are
          composed of one SH2 and two SH3 domains. Grb2/Sem-5/drk
          regulates the Ras pathway by linking the tyrosine
          kinases to the Ras guanine nucleotide releasing protein
          Sos, which converts Ras to the active GTP-bound state.
          The SH2 domain of Grb2/Sem-5/drk binds class II
          phosphotyrosyl peptides while its SH3 domain binds to
          Sos and Sos-derived, proline-rich peptides. Besides it
          function in Ras signaling, Grb2 is also thought to play
          a role in apoptosis. Unlike most SH2 structures in
          which the peptide binds in an extended conformation
          (such that the +3 peptide residue occupies a
          hydrophobic pocket in the protein, conferring a modest
          degree of selectivity), Grb2 forms several hydrogen
          bonds via main chain atoms with the side chain of +2
          Asn. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 95

 Score = 62.7 bits (153), Expect = 2e-14
 Identities = 31/82 (37%), Positives = 49/82 (59%), Gaps = 4/82 (4%)

Query: 8  DQRNWYHGSVTRHEAENILRNS-NEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPD 66
              W+HG ++R EAE IL N   +G++L+R SES+  D+SLS+K      H K+ RD  
Sbjct: 1  KPHPWFHGKISRAEAEEILMNQRPDGAFLIRESESSPGDFSLSVKFGNDVQHFKVLRDG- 59

Query: 67 TGKFILGQFSAPFDSVPEMIQH 88
           GK+ L  +   F+S+ E++ +
Sbjct: 60 AGKYFL--WVVKFNSLNELVDY 79


>gnl|CDD|198224 cd10361, SH2_Fps_family, Src homology 2 (SH2) domain found in
          feline sarcoma, Fujinami poultry sarcoma, and
          fes-related (Fes/Fps/Fer) proteins.  The Fps family
          consists of members Fps/Fes and Fer/Flk/Tyk3. They are
          cytoplasmic protein-tyrosine kinases implicated in
          signaling downstream from cytokines, growth factors and
          immune receptors.  Fes/Fps/Fer contains three
          coiled-coil regions, an SH2 (Src-homology-2) and a TK
          (tyrosine kinase catalytic) domain signature. Members
          here include: Fps/Fes, Fer, Kin-31, and  In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 90

 Score = 62.2 bits (152), Expect = 3e-14
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSE---SNRPDYSLSLKSARGFMHMKI 61
          K L+   +YHG + R +AE +L+  N+G +LVR +E     +    LS++      H  I
Sbjct: 1  KDLENEPYYHGLLPREDAEELLK--NDGDFLVRKTEPKGGGKRKLVLSVRWDGKIRHFVI 58

Query: 62 QRDPDTGKFILGQFSAPFDSVPEMIQHFAENRLPI 96
           RD     +I G     F S+ E+I ++ + + PI
Sbjct: 59 NRDDGGKYYIEG---KSFKSISELINYYQKTKEPI 90


>gnl|CDD|199827 cd09933, SH2_Src_family, Src homology 2 (SH2) domain found in the
          Src family of non-receptor tyrosine kinases.  The Src
          family kinases are nonreceptor tyrosine kinases that
          have been implicated in pathways regulating
          proliferation, angiogenesis, invasion and metastasis,
          and bone metabolism. It is thought that transforming
          ability of Src is linked to its ability to activate key
          signaling molecules in these pathways, rather than
          through direct activity. As such blocking Src
          activation has been a target for drug companies. Src
          family members can be divided into 3 groups based on
          their expression pattern: 1) Src, Fyn, and Yes; 2)
          Blk, Fgr, Hck, Lck, and Lyn; and 3) Frk-related kinases
          Frk/Rak and Iyk/Bsk Of these, cellular c-Src is the
          best studied and most frequently implicated in
          oncogenesis. The c-Src contains five distinct regions:
          a unique N-terminal domain, an SH3 domain, an SH2
          domain, a kinase domain and a regulatory tail, as do
          the other members of the family. Src exists in both
          active and inactive conformations. Negative regulation
          occurs through phosphorylation of Tyr, resulting in an
          intramolecular association between phosphorylated Tyr
          and the SH2 domain of SRC, which locks the protein in a
          closed conformation. Further stabilization of the
          inactive state occurs through interactions between the
          SH3 domain and a proline-rich stretch of residues
          within the kinase domain. Conversely, dephosphorylation
          of Tyr allows SRC to assume an open conformation. Full
          activity requires additional autophosphorylation of a
          Tyr residue within the catalytic domain. Loss of the
          negative-regulatory C-terminal segment has been shown
          to result in increased activity and transforming
          potential. Phosphorylation of the C-terminal Tyr
          residue by C-terminal Src kinase (Csk) and Csk homology
          kinase results in increased intramolecular interactions
          and consequent Src inactivation. Specific phosphatases,
          protein tyrosine phosphatase a (PTPa) and the
          SH-containing phosphatases SHP1/SHP2, have also been
          shown to take a part in Src activation. Src is also
          activated by direct binding of focal adhesion kinase
          (Fak) and Crk-associated substrate (Cas) to the SH2
          domain. SRC activity can also be regulated by numerous
          receptor tyrosine kinases (RTKs), such as Her2,
          epidermal growth factor receptor (EGFR), fibroblast
          growth factor receptor, platelet-derived growth factor
          receptor (PDGFR), and vascular endothelial growth
          factor receptor (VEGFR). In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 101

 Score = 61.4 bits (150), Expect = 9e-14
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 9/88 (10%)

Query: 12 WYHGSVTRHEAENILRNS--NEGSYLVRNSESNRPDYSLSLK---SARGFM--HMKIQRD 64
          W+ G + R +AE +L       G++L+R SE+    YSLS++    ARG    H +I R 
Sbjct: 5  WFFGKIKRKDAEKLLLAPGNPRGTFLIRESETTPGAYSLSVRDGDDARGDTVKHYRI-RK 63

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFAEN 92
           D G + +    A F ++ E++QH++++
Sbjct: 64 LDNGGYYITT-RATFPTLQELVQHYSKD 90


>gnl|CDD|198189 cd09935, SH2_ABL, Src homology 2 (SH2) domain found in Abelson
          murine lymphosarcoma virus (ABL) proteins.  ABL-family
          proteins are highly conserved tyrosine kinases. Each
          ABL protein contains an SH3-SH2-TK (Src homology 3-Src
          homology 2-tyrosine kinase) domain cassette, which
          confers autoregulated kinase activity and is common
          among nonreceptor tyrosine kinases. Several types of
          posttranslational modifications control ABL catalytic
          activity, subcellular localization, and stability, with
          consequences for both cytoplasmic and nuclear ABL
          functions. Binding partners provide additional
          regulation of ABL catalytic activity, substrate
          specificity, and downstream signaling. By combining
          this cassette with actin-binding and -bundling domain,
          ABL proteins are capable of connecting
          phosphoregulation with actin-filament reorganization.
          Vertebrate paralogs, ABL1 and ABL2, have evolved to
          perform specialized functions. ABL1 includes nuclear
          localization signals and a DNA binding domain which is
          used to mediate DNA damage-repair functions, while ABL2
          has additional binding capacity for actin and for
          microtubules to enhance its cytoskeletal remodeling
          functions.  SH2 is involved in several autoinhibitory
          mechanism that constrain the enzymatic activity of the
          ABL-family kinases. In one mechanism SH2 and SH3 cradle
          the kinase domain while a cap sequence stabilizes the
          inactive conformation resulting in a locked inactive
          state. Another involves phosphatidylinositol
          4,5-bisphosphate (PIP2) which binds the SH2 domain
          through residues normally required for phosphotyrosine
          binding in the linker segment between the SH2 and
          kinase domains. The SH2 domain contributes to ABL
          catalytic activity and target site specificity. It is
          thought that the ABL catalytic site and SH2 pocket have
          coevolved to recognize the same sequences. Recent work
          now supports a hierarchical processivity model in which
          the substrate target site most compatible with ABL
          kinase domain preferences is phosphorylated with
          greatest efficiency. If this site is compatible with
          the ABL SH2 domain specificity, it will then reposition
          and dock in the SH2 pocket. This mechanism also
          explains how ABL kinases phosphorylates poor targets on
          the same substrate if they are properly positioned and
          how relatively poor substrate proteins might be
          recruited to ABL through a complex with strong
          substrates that can also dock with the SH2 pocket. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 94

 Score = 61.3 bits (149), Expect = 9e-14
 Identities = 31/81 (38%), Positives = 49/81 (60%), Gaps = 2/81 (2%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          WYHG ++R+ AE +L +   GS+LVR SES+   YS+SL+      H +I  D D GK  
Sbjct: 5  WYHGPISRNAAEYLLSSGINGSFLVRESESSPGQYSISLRYDGRVYHYRISEDSD-GKVY 63

Query: 72 LGQFSAPFDSVPEMIQHFAEN 92
          + Q    F+++ E++ H ++N
Sbjct: 64 VTQ-EHRFNTLAELVHHHSKN 83


>gnl|CDD|198271 cd10408, SH2_Nck1, Src homology 2 (SH2) domain found in Nck.  Nck
           proteins are adaptors that modulate actin cytoskeleton
           dynamics by linking proline-rich effector molecules to
           tyrosine kinases or phosphorylated signaling
           intermediates. There are two members known in this
           family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth
           factor receptor-bound protein 4 (Grb4)). They are
           characterized by having 3 SH3 domains and a C-terminal
           SH2 domain. Nck1 and Nck2 have overlapping functions as
           determined by gene knockouts. Both bind receptor
           tyrosine kinases and other tyrosine-phosphorylated
           proteins through their SH2 domains. In addition they
           also bind distinct targets.  Neuronal signaling
           proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all
           bind to Nck-2 exclusively. And in the case of PDGFR,
           Tyr(P)751 binds to  Nck1 while Tyr(P)1009 binds to Nck2.
           Nck1 and Nck2 have a role in the infection process of
           enteropathogenic Escherichia coli (EPEC). Their SH3
           domains are involved in recruiting and activating the
           N-WASP/Arp2/3 complex inducing actin polymerization
           resulting in the production of pedestals, dynamic
           bacteria-presenting protrusions of the plasma membrane.
           A similar thing occurs in the vaccinia virus where
           motile plasma membrane projections are formed beneath
           the virus. Recently it has been shown that the SH2
           domains of both Nck1 and Nck2 bind the G-protein coupled
           receptor kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score = 60.4 bits (146), Expect = 2e-13
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 7/91 (7%)

Query: 12  WYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
           WY+G VTRH+AE  L    NEG +L+R+SES+  D+S+SLK+     H K+Q       +
Sbjct: 3   WYYGKVTRHQAEMALNERGNEGDFLIRDSESSPNDFSVSLKAQGKNKHFKVQLKECV--Y 60

Query: 71  ILGQFSAPFDSVPEMIQHFAENRLPILGAEH 101
            +GQ    F S+ E+++H+   + PI  +E 
Sbjct: 61  CIGQ--RKFSSMEELVEHY--KKAPIFTSEQ 87


>gnl|CDD|198178 cd09923, SH2_SOCS_family, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) family.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7). In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 81

 Score = 59.5 bits (145), Expect = 3e-13
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 15/85 (17%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          WY G +TR+EAE +L    EG++LVR+S  +R  +S+S ++    +H +I+       + 
Sbjct: 2  WYWGGITRYEAEELLAGKPEGTFLVRDSSDSRYLFSVSFRTYGRTLHARIE-------YS 54

Query: 72 LGQFS--------APFDSVPEMIQH 88
           G+FS          F  V E+I+H
Sbjct: 55 NGRFSFDSSDPSVPRFPCVVELIEH 79


>gnl|CDD|198186 cd09932, SH2_C-SH2_PLC_gamma_like, C-terminal Src homology 2
           (C-SH2) domain in Phospholipase C gamma.  Phospholipase
           C gamma is a signaling molecule that is recruited to the
           C-terminal tail of the receptor upon autophosphorylation
           of a highly conserved tyrosine. PLCgamma is composed of
           a Pleckstrin homology (PH) domain followed by an
           elongation factor (EF) domain, 2 catalytic regions of
           PLC domains that flank 2 tandem SH2 domains (N-SH2,
           C-SH2), and ending with a SH3 domain and C2 domain.
           N-SH2 SH2 domain-mediated interactions represent a
           crucial step in transmembrane signaling by receptor
           tyrosine kinases. SH2 domains recognize phosphotyrosine
           (pY) in the context of particular sequence motifs in
           receptor phosphorylation sites. Both N-SH2 and C-SH2
           have a very similar binding affinity to pY. But in
           growth factor stimulated cells these domains bind to
           different target proteins. N-SH2 binds to pY containing
           sites in the C-terminal tails of tyrosine kinases and
           other receptors. Recently it has been shown that this
           interaction is mediated by phosphorylation-independent
           interactions between a secondary binding site found
           exclusively on the N-SH2 domain and a region of the
           FGFR1 tyrosine kinase domain. This secondary site on the
           SH2 cooperates with the canonical pY site to regulate
           selectivity in mediating a specific cellular process.
           C-SH2 binds to an intramolecular site on PLCgamma itself
           which allows it to hydrolyze
           phosphatidylinositol-4,5-bisphosphate into
           diacylglycerol and inositol triphosphate. These then
           activate protein kinase C and release calcium. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 104

 Score = 59.2 bits (144), Expect = 6e-13
 Identities = 29/105 (27%), Positives = 64/105 (60%), Gaps = 11/105 (10%)

Query: 11  NWYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
            W+H ++TR +AE +L R   +G++LVR SE++   +++S ++     H +I+++   G+
Sbjct: 5   EWFHANLTREQAEEMLMRVPRDGAFLVRPSETDPNSFAISFRAEGKIKHCRIKQE---GR 61

Query: 70  -FILGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPMIEQLL 113
            F++G   + F+S+ E++ ++ ++ L       + L +P+ E+LL
Sbjct: 62  LFVIGT--SQFESLVELVSYYEKHPL----YRKIKLRYPVNEELL 100


>gnl|CDD|198200 cd10337, SH2_BCAR3, Src homology 2 (SH2) domain in the Breast
          Cancer Anti-estrogen Resistance protein 3.  BCAR3 is
          part of a growing family of guanine nucleotide exchange
          factors is responsible for activation of Ras-family
          GTPases, including Sos1 and 2, GRF1 and 2,
          CalDAG-GEF/GRP1-4, C3G, cAMP-GEF/Epac 1 and 2,
          PDZ-GEFs, MR-GEF, RalGDS family members, RalGPS,
          RasGEF, Smg GDS, and phospholipase C(epsilon). 12102558
           21262352  BCAR3 binds to the carboxy-terminus of
          BCAR1/p130Cas, a focal adhesion adapter protein.  Over
          expression of BCAR1 (p130Cas) and BCAR3 induces
          estrogen independent growth in normally
          estrogen-dependent cell lines. They have been linked to
          resistance to anti-estrogens in breast cancer, Rac
          activation, and cell motility, though the BCAR3/p130Cas
          complex is not required for this activity in BCAR3.
          Many BCAR3-mediated signaling events in epithelial and
          mesenchymal cells are independent of p130Cas
          association. Structurally these proteins contain a
          single SH2 domain upstream of their RasGEF domain,
          which is responsible for the ability of BCAR3 to
          enhance p130Cas over-expression-induced migration. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 136

 Score = 59.3 bits (144), Expect = 1e-12
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 11/92 (11%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRD---PDTG 68
          WYHG + R  AE++++   EG +LVR+S S+  DY L+ +     +H KI R    P   
Sbjct: 8  WYHGRIPRQVAESLVQ--REGDFLVRDSLSSPGDYVLTCRWKGQPLHFKINRVVLRPSEA 65

Query: 69 K----FILGQFSAPFDSVPEMIQHFAENRLPI 96
               +        FDS+P ++  +  NR PI
Sbjct: 66 YTRVQYQFEDEQ--FDSIPALVHFYVGNRRPI 95


>gnl|CDD|198195 cd09942, SH2_nSH2_p85_like, N-terminal Src homology 2 (nSH2) domain
           found in p85.  Phosphoinositide 3-kinases (PI3Ks) are
           essential for cell growth, migration, and survival.
           p110, the catalytic subunit, is composed of an
           adaptor-binding domain, a Ras-binding domain, a C2
           domain, a helical domain, and a kinase domain.  The
           regulatory unit is called p85 and is composed of an SH3
           domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain,
           an internal SH2 (iSH2) domain, and C-terminal (cSH2)
           domain.  There are 2 inhibitory interactions between
           p110alpha and p85 of P13K: (1) p85 nSH2 domain with the
           C2, helical, and kinase domains of p110alpha and (2) p85
           iSH2 domain with C2 domain of p110alpha. There are 3
           inhibitory interactions between p110beta and p85 of
           P13K: (1) p85 nSH2 domain with the C2, helical, and
           kinase domains of p110beta, (2) p85 iSH2 domain with C2
           domain of p110alpha, and (3) p85 cSH2 domain with the
           kinase domain of p110alpha. It is interesting to note
           that p110beta is oncogenic as a wild type protein while
           p110alpha lacks this ability. One explanation is the
           idea that the regulation of p110beta by p85 is unique
           because of the addition of inhibitory contacts from the
           cSH2 domain and the loss of contacts in the iSH2 domain.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 110

 Score = 58.5 bits (142), Expect = 2e-12
 Identities = 36/112 (32%), Positives = 61/112 (54%), Gaps = 16/112 (14%)

Query: 4   PKPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKI-Q 62
           P  L +  WY G ++R E    +R++ +G++LVR++ + + DY+L+L+       +KI  
Sbjct: 1   PHSLQEAEWYWGDISREEVNEKMRDTPDGTFLVRDASTMKGDYTLTLRKGGNNKLIKIFH 60

Query: 63  RDPDTGKFILGQFSAP--FDSVPEMIQHFAENRL----PILGAEHMCLLHPM 108
           RD   GK+    FS P  F+SV E+I ++  N L      L    + LL+P+
Sbjct: 61  RD---GKY---GFSDPLTFNSVVELINYYRNNSLAEYNRKL---DVKLLYPV 103


>gnl|CDD|198217 cd10354, SH2_Cterm_RasGAP, C-terminal Src homology 2 (SH2) domain
          found in Ras GTPase-activating protein 1 (GAP).  RasGAP
          is part of the GAP1 family of GTPase-activating
          proteins. The protein is located in the cytoplasm and
          stimulates the GTPase activity of normal RAS p21, but
          not its oncogenic counterpart. Acting as a suppressor
          of RAS function, the protein enhances the weak
          intrinsic GTPase activity of RAS proteins resulting in
          RAS inactivation, thereby allowing control of cellular
          proliferation and differentiation. Mutations leading to
          changes in the binding sites of either protein are
          associated with basal cell carcinomas. Alternative
          splicing results in two isoforms. The shorter isoform
          which lacks the N-terminal hydrophobic region, has the
          same activity, and is expressed in placental tissues.
          In general longer isoform contains 2 SH2 domains, a SH3
          domain, a pleckstrin homology (PH) domain, and a
          calcium-dependent phospholipid-binding C2 domain. The
          C-terminus contains the catalytic domain of RasGap
          which catalyzes the activation of Ras by hydrolyzing
          GTP-bound active Ras into an inactive GDP-bound form of
          Ras. This model contains the C-terminal SH2 domain. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 77

 Score = 56.3 bits (136), Expect = 5e-12
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 4/79 (5%)

Query: 12 WYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
          W+HG ++R EA N+L +    GS+LVR S++   DYSLS +   G  H KI    +    
Sbjct: 2  WFHGKISREEAYNMLVKVGGPGSFLVRESDNTPGDYSLSFRVNEGIKHFKIIPTGNNQFM 61

Query: 71 ILGQFSAPFDSVPEMIQHF 89
          + G++   F S+ ++I  +
Sbjct: 62 MGGRY---FSSLDDVIDRY 77


>gnl|CDD|198233 cd10370, SH2_Src_Src42, Src homology 2 (SH2) domain found in the
          Src oncogene at 42A (Src42).  Src42 is a member of the
          Src non-receptor type tyrosine kinase family of
          proteins. The integration of receptor tyrosine
          kinase-induced RAS and Src42 signals by Connector
          eNhancer of KSR (CNK) as a two-component input is
          essential for RAF activation in Drosophila. Src42 is
          present in a wide variety of organisms including:
          California sea hare, pea aphid, yellow fever mosquito,
          honey bee, Panamanian leafcutter ant, and sea urchin.
          Src42 has a unique N-terminal domain, an SH3 domain, an
          SH2 domain, a kinase domain and a regulatory tail, as
          do the other members of the family. Like the other
          members of the Src family the SH2 domain in addition to
          binding the target, also plays an autoinhibitory role
          by binding to its C-terminal tail.  In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 96

 Score = 56.7 bits (137), Expect = 6e-12
 Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 4/80 (5%)

Query: 12 WYHGSVTRHEAEN-ILRNSNE-GSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          WY G + R EAE  +L   NE G++L+R+SES   DYSLS++      H +I R  D G 
Sbjct: 5  WYFGKIKRIEAEKKLLLPENEHGAFLIRDSESRHNDYSLSVRDGDTVKHYRI-RQLDEGG 63

Query: 70 FILGQFSAPFDSVPEMIQHF 89
          F + +    F ++ E+++H+
Sbjct: 64 FFIAR-RTTFRTLQELVEHY 82


>gnl|CDD|198218 cd10355, SH2_DAPP1_BAM32_like, Src homology 2 domain found in dual
           adaptor for phosphotyrosine and 3-phosphoinositides (
           DAPP1)/B lymphocyte adaptor molecule of 32 kDa
           (Bam32)-like proteins.  DAPP1/Bam32 contains a putative
           myristoylation site at its N-terminus, followed by a SH2
           domain, and a pleckstrin homology (PH) domain at its
           C-terminus. DAPP1 could potentially be recruited to the
           cell membrane by any of these domains. Its putative
           myristoylation site could facilitate the interaction of
           DAPP1 with the lipid bilayer. Its SH2 domain may also
           interact with phosphotyrosine residues on
           membrane-associated proteins such as activated tyrosine
           kinase receptors. And finally its PH domain exhibits a
           high-affinity interaction with the PtdIns(3,4,5)P(3)
           PtdIns(3,4)P(2) second messengers produced at the cell
           membrane following the activation of PI 3-kinases. DAPP1
           is thought to interact with both tyrosine phosphorylated
           proteins and 3-phosphoinositides and therefore may play
           a role in regulating the location and/or activity of
           such proteins(s) in response to agonists that elevate
           PtdIns(3,4,5)P(3) and PtdIns(3,4)P(2). This protein is
           likely to play an important role in triggering signal
           transduction pathways that lie downstream from receptor
           tyrosine kinases and PI 3-kinase. It is likely that
           DAPP1 functions as an adaptor to recruit other proteins
           to the plasma membrane in response to extracellular
           signals. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 92

 Score = 55.9 bits (135), Expect = 1e-11
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 7/90 (7%)

Query: 12  WYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKF 70
           WYHG++TRH AE +L  N  +GSYL+RNS      +SLS+++     H  ++    + KF
Sbjct: 8   WYHGNLTRHAAEALLLSNGVDGSYLLRNSNEGTGLFSLSVRAKDSVKHFHVEYTGYSFKF 67

Query: 71  ILGQFSAPFDSVPEMIQHFAENRLPILGAE 100
              +FS    S+ + ++HFA    P++G+E
Sbjct: 68  GFNEFS----SLQDFVKHFANQ--PLIGSE 91


>gnl|CDD|198203 cd10340, SH2_N-SH2_SHP_like, N-terminal Src homology 2 (N-SH2)
          domain found in SH2 domain Phosphatases (SHP) proteins.
           The SH2 domain phosphatases (SHP-1, SHP-2/Syp,
          Drosophila corkscrew (csw), and Caenorhabditis elegans
          Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic
          signaling enzymes. They are both targeted and regulated
          by interactions of their SH2 domains with
          phosphotyrosine docking sites. These proteins contain
          two SH2 domains (N-SH2, C-SH2) followed by a tyrosine
          phosphatase (PTP) domain, and a C-terminal extension.
          Shp1 and Shp2 have two tyrosyl phosphorylation sites in
          their C-tails, which are phosphorylated differentially
          by receptor and nonreceptor PTKs. Csw retains the
          proximal tyrosine and Ptp-2 lacks both sites.
          Shp-binding proteins include receptors, scaffolding
          adapters, and inhibitory receptors. Some of these bind
          both Shp1 and Shp2 while others bind only one. Most
          proteins that bind a Shp SH2 domain contain one or more
          immuno-receptor tyrosine-based inhibitory motifs
          (ITIMs): [IVL]xpYxx[IVL].  Shp1 N-SH2 domain blocks the
          catalytic domain and keeps the enzyme in the inactive
          conformation, and is thus believed to regulate the
          phosphatase activity of SHP-1. Its C-SH2 domain is
          thought to be involved in searching for phosphotyrosine
          activators. The SHP2 N-SH2 domain is a conformational
          switch; it either binds and inhibits the phosphatase,
          or it binds phosphoproteins and activates the enzyme.
          The C-SH2 domain contributes binding energy and
          specificity, but it does not have a direct role in
          activation. Csw SH2 domain function is essential, but
          either SH2 domain can fulfill this requirement. The
          role of the csw SH2 domains during Sevenless receptor
          tyrosine kinase (SEV) signaling is to bind Daughter of
          Sevenless rather than activated SEV.  Ptp-2 acts in
          oocytes downstream of sheath/oocyte gap junctions to
          promote major sperm protein (MSP)-induced MAP Kinase
          (MPK-1) phosphorylation. Ptp-2 functions in the oocyte
          cytoplasm, not at the cell surface to inhibit multiple
          RasGAPs, resulting in sustained Ras activation. It is
          thought that MSP triggers PTP-2/Ras activation and ROS
          production to stimulate MPK-1 activity essential for
          oocyte maturation and that secreted MSP domains and
          Cu/Zn superoxide dismutases function antagonistically
          to control ROS and MAPK signaling. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 99

 Score = 55.5 bits (134), Expect = 2e-11
 Identities = 27/83 (32%), Positives = 47/83 (56%), Gaps = 4/83 (4%)

Query: 11 NWYHGSVTRHEAENILRNSNE-GSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
           W+H  ++  EAEN+L+     GS+L R S+SN  D++LS++      H+KIQ   +TG 
Sbjct: 1  RWFHPVISGIEAENLLKTRGVDGSFLARPSKSNPGDFTLSVRRGDEVTHIKIQ---NTGD 57

Query: 70 FILGQFSAPFDSVPEMIQHFAEN 92
          +        F ++ E++Q++ E 
Sbjct: 58 YYDLYGGEKFATLSELVQYYMEQ 80


>gnl|CDD|198230 cd10367, SH2_Src_Fgr, Src homology 2 (SH2) domain found in
          Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene
          homolog, Fgr.  Fgr is a member of the Src non-receptor
          type tyrosine kinase family of proteins. The protein
          contains N-terminal sites for myristoylation and
          palmitoylation, a PTK domain, and SH2 and SH3 domains
          which are involved in mediating protein-protein
          interactions with phosphotyrosine-containing and
          proline-rich motifs, respectively. Fgr is expressed in
          B-cells and myeloid cells, localizes to plasma membrane
          ruffles, and functions as a negative regulator of cell
          migration and adhesion triggered by the beta-2 integrin
          signal transduction pathway. Multiple alternatively
          spliced variants, encoding the same protein, have been
          identified  Fgr has been shown to interact with
          Wiskott-Aldrich syndrome protein. Fgr has a unique
          N-terminal domain, an SH3 domain, an SH2 domain, a
          kinase domain and a regulatory tail, as do the other
          members of the family. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 101

 Score = 54.9 bits (132), Expect = 4e-11
 Identities = 33/87 (37%), Positives = 49/87 (56%), Gaps = 9/87 (10%)

Query: 12 WYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSLK---SARG--FMHMKIQRD 64
          WY G + R +AE  L +     G++L+R SE+ +  YSLS++     RG    H KI R 
Sbjct: 5  WYFGKIGRKDAERQLLSPGNPRGAFLIRESETTKGAYSLSIRDWDQNRGDHVKHYKI-RK 63

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFAE 91
           DTG + +    A FD+V E++QH+ E
Sbjct: 64 LDTGGYYITT-RAQFDTVQELVQHYME 89


>gnl|CDD|198211 cd10348, SH2_Cterm_shark_like, C-terminal Src homology 2 (SH2)
          domain found in SH2 domains, ANK, and kinase domain
          (shark) proteins.  These non-receptor protein-tyrosine
          kinases contain two SH2 domains, five ankyrin
          (ANK)-like repeats, and a potential tyrosine
          phosphorylation site in its carboxyl-terminal tail
          which resembles the phosphorylation site in members of
          the src family. Like, mammalian non-receptor
          protein-tyrosine kinases, ZAP-70 and syk proteins, they
          do not have SH3 domains. However, the presence of ANK
          makes these unique among protein-tyrosine kinases. Both
          tyrosine kinases and ANK repeats have been shown to
          transduce developmental signals, and SH2 domains are
          known to participate intimately in tyrosine kinase
          signaling. These tyrosine kinases are believed to be
          involved in epithelial cell polarity. The members of
          this family include the shark (SH2 domains, ANK, and
          kinase domain) gene in Drosophila and yellow fever
          mosquitos, as well as the hydra protein HTK16.
          Drosophila Shark is proposed to transduce
          intracellularly the Crumbs, a protein necessary for
          proper organization of ectodermal epithelia,
          intercellular signal. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 86

 Score = 53.6 bits (129), Expect = 7e-11
 Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 6/81 (7%)

Query: 12 WYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W HG++ R+EA  IL+     +GS+LVR S      Y L+L       H +IQ   D   
Sbjct: 2  WLHGALDRNEAVEILKQKADADGSFLVRYSRRRPGGYVLTLVYENHVYHFEIQNRDDKWF 61

Query: 70 FILGQFSAP-FDSVPEMIQHF 89
          +I      P F+S+  +I+H+
Sbjct: 62 YI---DDGPYFESLEHLIEHY 79


>gnl|CDD|198285 cd10718, SH2_CIS, Src homology 2 (SH2) domain found in
          cytokine-inducible SH2-containing protein (CIS).  CIS
          family members are known to be cytokine-inducible
          negative regulators of cytokine signaling. The
          expression of the CIS gene can be induced by IL2, IL3,
          GM-CSF and EPO in hematopoietic cells.
          Proteasome-mediated degradation of this protein has
          been shown to be involved in the inactivation of the
          erythropoietin receptor. Suppressor of cytokine
          signalling (SOCS) was first recognized as a group of
          cytokine-inducible SH2 (CIS) domain proteins comprising
          eight family members in human (CIS and SOCS1-SOCS7).
          In addition to the SH2 domain, SOCS proteins have a
          variable N-terminal domain and a conserved SOCS box in
          the C-terminal domain. SOCS proteins bind to a
          substrate via their SH2 domain. The prototypical
          members, CIS and SOCS1-SOCS3, have been shown to
          regulate growth hormone signaling in vitro and in a
          classic negative feedback response compete for binding
          at phosphotyrosine sites in JAK kinase and receptor
          pathways to displace effector proteins and target bound
          receptors for proteasomal degradation. Loss of SOCS
          activity results in excessive cytokine signaling
          associated with a variety of hematopoietic, autoimmune,
          and inflammatory diseases and certain cancers. In
          general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 88

 Score = 53.6 bits (129), Expect = 8e-11
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 12/91 (13%)

Query: 7  LDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDY--SLSLKSARGFMHMKIQRD 64
          L +  WY GS+T  EA   L+ + EG++LVR  +S+ P Y  +LS+K+ RG  +++I+  
Sbjct: 1  LRESGWYWGSITASEAHQALQKAPEGTFLVR--DSSHPSYMLTLSVKTTRGPTNVRIEY- 57

Query: 65 PDTGKFILGQFSA------PFDSVPEMIQHF 89
             G F L   S        F  V  ++QH+
Sbjct: 58 -SDGSFRLDSSSLARPRLLSFPDVVSLVQHY 87


>gnl|CDD|198185 cd09931, SH2_C-SH2_SHP_like, C-terminal Src homology 2 (C-SH2)
           domain found in SH2 domain Phosphatases (SHP) proteins. 
           The SH2 domain phosphatases (SHP-1, SHP-2/Syp,
           Drosophila corkscrew (csw), and Caenorhabditis elegans
           Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic
           signaling enzymes. They are both targeted and regulated
           by interactions of their SH2 domains with
           phosphotyrosine docking sites. These proteins contain
           two SH2 domains (N-SH2, C-SH2) followed by a tyrosine
           phosphatase (PTP) domain, and a C-terminal extension.
           Shp1 and Shp2 have two tyrosyl phosphorylation sites in
           their C-tails, which are phosphorylated differentially
           by receptor and nonreceptor PTKs. Csw retains the
           proximal tyrosine and Ptp-2 lacks both sites.
           Shp-binding proteins include receptors, scaffolding
           adapters, and inhibitory receptors. Some of these bind
           both Shp1 and Shp2 while others bind only one. Most
           proteins that bind a Shp SH2 domain contain one or more
           immuno-receptor tyrosine-based inhibitory motifs
           (ITIMs): [SIVL]xpYxx[IVL].  Shp1 N-SH2 domain blocks the
           catalytic domain and keeps the enzyme in the inactive
           conformation, and is thus believed to regulate the
           phosphatase activity of SHP-1. Its C-SH2 domain is
           thought to be involved in searching for phosphotyrosine
           activators.  The SHP2 N-SH2 domain is a conformational
           switch; it either binds and inhibits the phosphatase, or
           it binds phosphoproteins and activates the enzyme. The
           C-SH2 domain contributes binding energy and specificity,
           but it does not have a direct role in activation. Csw
           SH2 domain function is essential, but either SH2 domain
           can fulfill this requirement. The role of the csw SH2
           domains during Sevenless receptor tyrosine kinase (SEV)
           signaling is to bind Daughter of Sevenless rather than
           activated SEV. Ptp-2 acts in oocytes downstream of
           sheath/oocyte gap junctions to promote major sperm
           protein (MSP)-induced MAP Kinase (MPK-1)
           phosphorylation. Ptp-2 functions in the oocyte
           cytoplasm, not at the cell surface to inhibit multiple
           RasGAPs, resulting in sustained Ras activation. It is
           thought that MSP triggers PTP-2/Ras activation and ROS
           production to stimulate MPK-1 activity essential for
           oocyte maturation and that secreted MSP domains and
           Cu/Zn superoxide dismutases function antagonistically to
           control ROS and MAPK signaling. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 99

 Score = 53.4 bits (129), Expect = 1e-10
 Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 5/98 (5%)

Query: 12  WYHGSVTRHEAENILRNSNE-GSYLVRNSESNRPDYSLSLKSARG-FMHMKIQRDPDTGK 69
           W+HG ++  EAE +L    + GS+LVR S+S   D+ LS+++      H+ I+       
Sbjct: 2   WFHGHLSGKEAEKLLLEKGKPGSFLVRESQSKPGDFVLSVRTDDDKVTHIMIRCQGGKYD 61

Query: 70  FILGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHP 107
              G+    FDS+ ++++H+ +N +       + L  P
Sbjct: 62  VGGGE---EFDSLTDLVEHYKKNPMVETSGTVVHLKQP 96


>gnl|CDD|198250 cd10387, SH2_SOCS6, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7). In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 100

 Score = 53.3 bits (128), Expect = 1e-10
 Identities = 29/84 (34%), Positives = 44/84 (52%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRD 64
          K L ++ WY G +TR EAE  L N  +GS+LVR+S  +R   SLS +S    +H +I+  
Sbjct: 5  KKLAKQGWYWGPITRWEAEGKLANVPDGSFLVRDSSDDRYLLSLSFRSHGKTLHTRIEHS 64

Query: 65 PDTGKFILGQFSAPFDSVPEMIQH 88
               F          S+ ++I+H
Sbjct: 65 NGRFSFYEQPDVEGHTSIVDLIEH 88


>gnl|CDD|198179 cd09925, SH2_SHC, Src homology 2 (SH2) domain found in SH2 adaptor
           protein C (SHC).  SHC is involved in a wide variety of
           pathways including regulating proliferation,
           angiogenesis, invasion and metastasis, and bone
           metabolism. An adapter protein, SHC has been implicated
           in Ras activation following the stimulation of a number
           of different receptors, including growth factors
           [insulin, epidermal growth factor (EGF), nerve growth
           factor, and platelet derived growth factor (PDGF)],
           cytokines [interleukins 2, 3, and 5], erythropoietin,
           and granulocyte/macrophage colony-stimulating factor,
           and antigens [T-cell and B-cell receptors]. SHC has been
           shown to bind to tyrosine-phosphorylated receptors, and
           receptor stimulation leads to tyrosine phosphorylation
           of SHC. Upon phosphorylation, SHC interacts with another
           adapter protein, Grb2, which binds to the Ras GTP/GDP
           exchange factor mSOS which leads to Ras activation. SHC
           is composed of an N-terminal domain that interacts with
           proteins containing phosphorylated tyrosines, a
           (glycine/proline)-rich collagen-homology domain that
           contains the phosphorylated binding site, and a
           C-terminal SH2 domain. SH2 has been shown to interact
           with the tyrosine-phosphorylated receptors of EGF and
           PDGF and with the tyrosine-phosphorylated C chain of the
           T-cell receptor, providing one of the mechanisms of
           T-cell-mediated Ras activation. In general SH2 domains
           are involved in signal transduction.  They typically
           bind pTyr-containing ligands via two surface pockets, a
           pTyr and hydrophobic binding pocket, allowing proteins
           with SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 104

 Score = 52.7 bits (127), Expect = 3e-10
 Identities = 29/106 (27%), Positives = 47/106 (44%), Gaps = 13/106 (12%)

Query: 6   PLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDP 65
            L    WYHG ++R +AE++L+   +G +LVR S +    Y L+        H+ +  DP
Sbjct: 3   QLRGEPWYHGKMSRRDAESLLQ--TDGDFLVRESTTTPGQYVLTGMQNGQPKHL-LLVDP 59

Query: 66  DTGKFILGQFS---APFDSVPEMIQHFAENRLPILGAEHM-CLLHP 107
           +      G        F+S+  +I +   N LPI+       L  P
Sbjct: 60  E------GVVRTKDRVFESISHLINYHVTNGLPIISEGSELHLRRP 99


>gnl|CDD|198215 cd10352, SH2_a2chimerin_b2chimerin, Src homology 2 (SH2) domain
          found in alpha2-chimerin and beta2-chimerin proteins.
          Chimerins are a family of phorbol ester- and
          diacylglycerol-responsive GTPase-activating proteins.
          Alpha1-chimerin (formerly known as n-chimerin) and
          alpha2-chimerin are alternatively spliced products of a
          single gene, as are beta1- and beta2-chimerin. alpha1-
          and beta1-chimerin have a relatively short N-terminal
          region that does not encode any recognizable domains,
          whereas alpha2- and beta2-chimerin both include a
          functional SH2 domain that can bind to phosphotyrosine
          motifs within receptors. All of the isoforms contain a
          GAP domain with specificity in vitro for Rac1 and a
          diacylglycerol (DAG)-binding C1 domain which allows
          them to translocate to membranes in response to DAG
          signaling and anchors them in close proximity to
          activated Rac. Other C1 domain-containing
          diacylglycerol receptors including: PKC, Munc-13
          proteins, phorbol ester binding scaffolding proteins
          involved in Ca2+-stimulated exocytosis, and RasGRPs,
          diacylglycerol-activated guanine-nucleotide exchange
          factors (GEFs) for Ras and Rap1. In general SH2 domains
          are involved in signal transduction. They typically
          bind pTyr-containing ligands via two surface pockets, a
          pTyr and hydrophobic binding pocket, allowing proteins
          with SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 91

 Score = 52.0 bits (125), Expect = 4e-10
 Identities = 23/74 (31%), Positives = 42/74 (56%), Gaps = 2/74 (2%)

Query: 13 YHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFIL 72
          YHG ++R EAE +L  +++GSYL+R S  +   Y+LSL+      + K+  D       +
Sbjct: 9  YHGLISREEAEQLLSGASDGSYLIRESSRDDGYYTLSLRFNGKVKNYKLYYDGKNHYHYV 68

Query: 73 GQFSAPFDSVPEMI 86
          G+    FD++ +++
Sbjct: 69 GEKR--FDTIHDLV 80


>gnl|CDD|199831 cd10369, SH2_Src_Frk, Src homology 2 (SH2) domain found in the
          Fyn-related kinase (Frk).  Frk is a member of the Src
          non-receptor type tyrosine kinase family of proteins.
          The Frk subfamily is composed of Frk/Rak and
          Iyk/Bsk/Gst. It is expressed primarily epithelial
          cells.  Frk is a nuclear protein and may function
          during G1 and S phase of the cell cycle and suppress
          growth. Unlike the other Src members it lacks a glycine
          at position 2 of SH4 which is important for addition of
          a myristic acid moiety that is involved in targeting
          Src PTKs to cellular membranes. FRK and SHB exert
          similar effects when overexpressed in rat
          phaeochromocytoma (PC12) and beta-cells, where both
          induce PC12 cell differentiation and beta-cell
          proliferation. Under conditions that cause beta-cell
          degeneration these proteins augment beta-cell
          apoptosis. The FRK-SHB responses involve FAK and
          insulin receptor substrates (IRS) -1 and -2. Frk has
          been demonstrated to interact with retinoblastoma
          protein. Frk regulates PTEN protein stability by
          phosphorylating PTEN, which in turn prevents PTEN
          degradation. Frk also plays a role in regulation of
          embryonal pancreatic beta cell formation. Frk has a
          unique N-terminal domain, an SH3 domain, an SH2 domain,
          a kinase domain and a regulatory tail, as do the other
          members of the family.  Like the other members of the
          Src family the SH2 domain in addition to binding the
          target, also plays an autoinhibitory role by binding to
          its activation loop. The tryosine involved is at the
          same site as the tyrosine involved in the
          autophosphorylation of Src. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 96

 Score = 52.2 bits (125), Expect = 4e-10
 Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 4/83 (4%)

Query: 12 WYHGSVTRHEAENIL--RNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W+ G++ R +AE  L    +  G++L+R SES + ++SLS+       H +I+R  D G 
Sbjct: 5  WFFGAIKRADAEKQLLYSENQTGAFLIRESESQKGEFSLSVLDGGVVKHYRIRR-LDEGG 63

Query: 70 FILGQFSAPFDSVPEMIQHFAEN 92
          F L +    F ++ E + ++   
Sbjct: 64 FFLTRRKT-FSTLNEFVNYYTTT 85


>gnl|CDD|198229 cd10366, SH2_Src_Yes, Src homology 2 (SH2) domain found in Yes.
          Yes is a member of the Src non-receptor type tyrosine
          kinase family of proteins. Yes is the cellular homolog
          of the Yamaguchi sarcoma virus oncogene. In humans it
          is encoded by the YES1 gene which maps to chromosome 18
          and is in close proximity to thymidylate synthase. A
          corresponding Yes pseudogene has been found on
          chromosome 22. YES1 has been shown to interact with
          Janus kinase 2, CTNND1,RPL10, and Occludin. Yes1 has a
          unique N-terminal domain, an SH3 domain, an SH2 domain,
          a kinase domain and a regulatory tail, as do the other
          members of the family. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 101

 Score = 51.9 bits (124), Expect = 5e-10
 Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 9/88 (10%)

Query: 12 WYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLK---SARG--FMHMKIQRD 64
          WY G + R +AE +L N  +  G +LVR SE+ +  YSLS++     RG    H KI++ 
Sbjct: 5  WYFGKMGRKDAERLLLNPGNQRGIFLVRESETTKGAYSLSIRDWDEVRGDNVKHYKIRKL 64

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFAEN 92
           + G +I  +  A FD++ ++++H+ E+
Sbjct: 65 DNGGYYITTR--AQFDTLQKLVKHYTEH 90


>gnl|CDD|198281 cd10418, SH2_Src_Fyn_isoform_a_like, Src homology 2 (SH2) domain
          found in Fyn isoform a like proteins.  Fyn is a member
          of the Src non-receptor type tyrosine kinase family of
          proteins. This cd contains the SH2 domain found in Fyn
          isoform a type proteins.  Fyn is involved in the
          control of cell growth and is required in the following
          pathways: T and B cell receptor signaling,
          integrin-mediated signaling, growth factor and cytokine
          receptor signaling, platelet activation, ion channel
          function, cell adhesion, axon guidance, fertilization,
          entry into mitosis, and differentiation of natural
          killer cells, oligodendrocytes and keratinocytes. The
          protein associates with the p85 subunit of
          phosphatidylinositol 3-kinase and interacts with the
          Fyn-binding protein. Alternatively spliced transcript
          variants encoding distinct isoforms exist. Fyn is
          primarily localized to the cytoplasmic leaflet of the
          plasma membrane. Tyrosine phosphorylation of target
          proteins by Fyn serves to either regulate target
          protein activity, and/or to generate a binding site on
          the target protein that recruits other signaling
          molecules. FYN has been shown to interact with a number
          of proteins including: BCAR1, Cbl, Janus kinase,
          nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome
          protein, and Zap-70. Fyn has a unique N-terminal
          domain, an SH3 domain, an SH2 domain, a kinase domain
          and a regulatory tail, as do the other members of the
          family. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 51.5 bits (123), Expect = 7e-10
 Identities = 28/89 (31%), Positives = 52/89 (58%), Gaps = 9/89 (10%)

Query: 10 RNWYHGSVTRHEAE-NILRNSN-EGSYLVRNSESNRPDYSLSLK---SARG--FMHMKIQ 62
            WY G + R +AE  +L   N  G++L+R SE+ +  YSLS++     +G    H KI+
Sbjct: 3  EEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR 62

Query: 63 RDPDTGKFILGQFSAPFDSVPEMIQHFAE 91
          +  + G +I  +  A F+++ +++QH++E
Sbjct: 63 KLDNGGYYITTR--AQFETLQQLVQHYSE 89


>gnl|CDD|198214 cd10351, SH2_SH2D4B, Src homology 2 domain found in the SH2
          domain containing protein 4B (SH2D4B).  SH2D4B contains
          a single SH2 domain. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 103

 Score = 51.0 bits (122), Expect = 1e-09
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 1/60 (1%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          W+HG ++R EAE +L N+ EGS+LVR SE     Y+LS +   GF H  +    D   F+
Sbjct: 9  WFHGIISREEAEALLMNATEGSFLVRVSEKIW-GYTLSYRLQSGFKHFLVDASGDFYSFL 67


>gnl|CDD|199829 cd10341, SH2_N-SH2_PLC_gamma_like, N-terminal Src homology 2
          (N-SH2) domain in Phospholipase C gamma.  Phospholipase
          C gamma is a signaling molecule that is recruited to
          the C-terminal tail of the receptor upon
          autophosphorylation of a highly conserved tyrosine.
          PLCgamma is composed of a Pleckstrin homology (PH)
          domain followed by an elongation factor (EF) domain, 2
          catalytic regions of PLC domains that flank 2 tandem
          SH2 domains (N-SH2, C-SH2), and ending with a SH3
          domain and C2 domain. N-SH2 SH2 domain-mediated
          interactions represent a crucial step in transmembrane
          signaling by receptor tyrosine kinases. SH2 domains
          recognize phosphotyrosine (pY) in the context of
          particular sequence motifs in receptor phosphorylation
          sites. Both N-SH2 and C-SH2 have a very similar binding
          affinity to pY. But in growth factor stimulated cells
          these domains bind to different target proteins. N-SH2
          binds to pY containing sites in the C-terminal tails of
          tyrosine kinases and other receptors. Recently it has
          been shown that this interaction is mediated by
          phosphorylation-independent interactions between a
          secondary binding site found exclusively on the N-SH2
          domain and a region of the FGFR1 tyrosine kinase
          domain. This secondary site on the SH2 cooperates with
          the canonical pY site to regulate selectivity in
          mediating a specific cellular process.  C-SH2 binds to
          an intramolecular site on PLCgamma itself which allows
          it to hydrolyze phosphatidylinositol-4,5-bisphosphate
          into diacylglycerol and inositol triphosphate. These
          then activate protein kinase C and release calcium. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 99

 Score = 50.8 bits (122), Expect = 1e-09
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 11 NWYHGSVT--RHEAENILR---NSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDP 65
           W+HG +   R EAE +L       +G++LVR SE+   DY+LS        H +I+   
Sbjct: 5  PWFHGKLGDGRDEAEKLLLEYCEGGDGTFLVRESETFVGDYTLSFWRNGKVQHCRIRSRQ 64

Query: 66 DTG--KFILGQFSAPFDSVPEMIQHFAENRL 94
          + G  K+ L   +  FDS+ E+I ++ +N L
Sbjct: 65 ENGEKKYYLTD-NLVFDSLYELIDYYRQNPL 94


>gnl|CDD|198191 cd09938, SH2_N-SH2_Zap70_Syk_like, N-terminal Src homology 2
          (SH2) domain found in Zeta-chain-associated protein
          kinase 70 (ZAP-70) and Spleen tyrosine kinase (Syk)
          proteins.  ZAP-70 and Syk comprise a family of
          hematopoietic cell specific protein tyrosine kinases
          (PTKs) that are required for antigen and antibody
          receptor function. ZAP-70 is expressed in T and natural
          killer (NK) cells and Syk is expressed in B cells, mast
          cells, polymorphonuclear leukocytes, platelets,
          macrophages, and immature T cells. They are required
          for the proper development of T and B cells, immune
          receptors, and activating NK cells. They consist of two
          N-terminal Src homology 2 (SH2) domains and a
          C-terminal kinase domain separated from the SH2 domains
          by a linker or hinge region. Phosphorylation of both
          tyrosine residues within the Immunoreceptor
          Tyrosine-based Activation Motifs (ITAM; consensus
          sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs
          is required for efficient interaction of ZAP-70 and Syk
          with the receptor subunits and for receptor function.
          ZAP-70 forms two phosphotyrosine binding pockets, one
          of which is shared by both SH2 domains.  In Syk the two
          SH2 domains do not form such a phosphotyrosine-binding
          site.  The SH2 domains here are believed to function
          independently. In addition, the two SH2 domains of Syk
          display flexibility in their relative orientation,
          allowing Syk to accommodate a greater variety of
          spacing sequences between the ITAM phosphotyrosines and
          singly phosphorylated non-classical ITAM ligands. This
          model contains the N-terminus SH2 domains of both Syk
          and Zap70. In general SH2 domains are involved in
          signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 104

 Score = 50.5 bits (121), Expect = 2e-09
 Identities = 23/83 (27%), Positives = 40/83 (48%), Gaps = 4/83 (4%)

Query: 11 NWYHGSVTRHEAENILR--NSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTG 68
           +++GS+TR EAE  L+    ++G +L+R S  +   Y LS+   R F H  I+R  +  
Sbjct: 2  PFFYGSITREEAEEYLKLAGMSDGLFLLRQSLRSLGGYVLSVCHGRKFHHYTIERQLNGT 61

Query: 69 KFILGQFSAPFDSVPEMIQHFAE 91
            I G          E+ ++ + 
Sbjct: 62 YAIAG--GKAHCGPAELCEYHST 82


>gnl|CDD|198188 cd09934, SH2_Tec_family, Src homology 2 (SH2) domain found in
          Tec-like proteins.  The Tec protein tyrosine kinase is
          the founding member of a family that includes Btk, Itk,
          Bmx, and Txk. The members have a PH domain, a
          zinc-binding motif, a SH3 domain, a SH2 domain, and a
          protein kinase catalytic domain. Btk is involved in
          B-cell receptor signaling with mutations in Btk
          responsible for X-linked agammaglobulinemia (XLA) in
          humans and X-linked immunodeficiency (xid) in mice. Itk
          is involved in T-cell receptor signaling. Tec is
          expressed in both T and B cells, and is thought to
          function in activated and effector T lymphocytes to
          induce the expression of genes regulated by NFAT
          transcription factors. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 104

 Score = 50.1 bits (120), Expect = 2e-09
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 20/97 (20%)

Query: 7  LDQRNWYHGSVTRHEAENILR-NSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDP 65
          L++  WY G ++R  AE++L+    EG ++VRNS S +  Y++SL         K+   P
Sbjct: 3  LEKYEWYVGDMSRQRAESLLKQEDKEGCFVVRNS-STKGLYTVSL-------FTKVPGSP 54

Query: 66 ----------DTGKFILGQFSAPFDSVPEMIQHFAEN 92
                       +F L +    F+++PE+I +   N
Sbjct: 55 HVKHYHIKQNARSEFYLAEKHC-FETIPELINYHQHN 90


>gnl|CDD|198246 cd10383, SH2_SOCS2, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7).  In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 103

 Score = 49.5 bits (118), Expect = 5e-09
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 10/92 (10%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQ-R 63
          + L Q  WY GS+T +EA+  L+++ EG++LVR+S  +    ++S+K++ G  +++I+ +
Sbjct: 2  RELSQTGWYWGSMTVNEAKEKLQDAPEGTFLVRDSSHSDYLLTISVKTSAGPTNLRIEYQ 61

Query: 64 DPDTGKFILGQFS------APFDSVPEMIQHF 89
          D   GKF L            FDSV  +I+++
Sbjct: 62 D---GKFRLDSIICVKSKLKQFDSVVHLIEYY 90


>gnl|CDD|198268 cd10405, SH2_Vav1, Src homology 2 (SH2) domain found in the Vav1
          proteins.  Proto-oncogene vav is a member of the Dbl
          family of guanine nucleotide exchange factors (GEF) for
          the Rho family of GTP binding proteins.  All vavs are
          activated by tyrosine phosphorylation leading to their
          activation. There are three Vav mammalian family
          members: Vav1 which is expressed in the hematopoietic
          system, and Vav2 and Vav3 are more ubiquitously
          expressed. Vav1 plays a role in T-cell and B-cell
          development and activation.  It has been identified as
          the specific binding partner of Nef proteins from
          HIV-1, resulting in morphological changes, cytoskeletal
          rearrangements, and the JNK/SAPK signaling cascade,
          leading to increased levels of viral transcription and
          replication. Vav1 has been shown to interact with Ku70,
          PLCG1, Lymphocyte cytosolic protein 2, Janus kinase 2,
          SIAH2, S100B, Abl gene, ARHGDIB, SHB, PIK3R1, PRKCQ,
          Grb2, MAPK1, Syk, Linker of activated T cells, Cbl gene
          and EZH2. Vav proteins are involved in several
          processes that require cytoskeletal reorganization,
          such as the formation of the immunological synapse
          (IS), phagocytosis, platelet aggregation, spreading,
          and transformation.  Vavs function as guanine
          nucleotide exchange factors (GEFs) for the Rho/Rac
          family of GTPases. Vav family members have several
          conserved motifs/domains including: a leucine-rich
          region, a leucine-zipper, a calponin homology (CH)
          domain, an acidic domain, a Dbl-homology (DH) domain, a
          pleckstrin homology (PH) domain, a cysteine-rich
          domain, 2 SH3 domains, a proline-rich region, and a SH2
          domain.  Vavs are the only known Rho GEFs that have
          both the DH/PH motifs and SH2/SH3 domains in the same
          protein. The leucine-rich helix-loop-helix (HLH) domain
          is thought to be involved in protein heterodimerization
          with other HLH proteins and it may function as a
          negative regulator by forming inactive heterodimers.
          The CH domain  is usually involved in the association
          with filamentous actin, but in Vav it controls NFAT
          stimulation, Ca2+ mobilization, and its transforming
          activity. Acidic domains are involved in
          protein-protein interactions and contain regulatory
          tyrosines. The DH domain is a GDP-GTP exchange factor
          on Rho/Rac GTPases. The PH domain in involved in
          interactions with GTP-binding proteins, lipids and/or
          phosphorylated serine/threonine residues.  The SH3
          domain is involved in localization of proteins to
          specific sites within the cell interacting with protein
          with proline-rich sequences. The SH2 domain mediates a
          high affinity interaction with tyrosine phosphorylated
          proteins. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 103

 Score = 49.2 bits (117), Expect = 5e-09
 Identities = 25/83 (30%), Positives = 46/83 (55%), Gaps = 3/83 (3%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          WY G + R  AE+IL N ++G+YLVR    +  ++++S+K      H+KI      G + 
Sbjct: 7  WYAGPMERAGAESILANRSDGTYLVRQRVKDAAEFAISIKYNVEVKHIKIM--TAEGLYR 64

Query: 72 LGQFSAPFDSVPEMIQHFAENRL 94
          + +  A F  + E+++ + +N L
Sbjct: 65 ITEKKA-FRGLTELVEFYQQNSL 86


>gnl|CDD|198210 cd10347, SH2_Nterm_shark_like, N-terminal Src homology 2 (SH2)
          domain found in SH2 domains, ANK, and kinase domain
          (shark) proteins.  These non-receptor protein-tyrosine
          kinases contain two SH2 domains, five ankyrin
          (ANK)-like repeats, and a potential tyrosine
          phosphorylation site in the carboxyl-terminal tail
          which resembles the phosphorylation site in members of
          the src family. Like, mammalian non-receptor
          protein-tyrosine kinases, ZAP-70 and syk proteins, they
          do not have SH3 domains. However, the presence of ANK
          makes these unique among protein-tyrosine kinases. Both
          tyrosine kinases and ANK repeats have been shown to
          transduce developmental signals, and SH2 domains are
          known to participate intimately in tyrosine kinase
          signaling. These tyrosine kinases are believed to be
          involved in epithelial cell polarity. The members of
          this family include the shark (SH2 domains, ANK, and
          kinase domain) gene in Drosophila and yellow fever
          mosquitos, as well as the hydra protein HTK16.
          Drosophila Shark is proposed to transduce
          intracellularly the Crumbs, a protein necessary for
          proper organization of ectodermal epithelia,
          intercellular signal. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 81

 Score = 48.5 bits (116), Expect = 5e-09
 Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 3/81 (3%)

Query: 11 NWYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTG 68
           WYHG ++R  AE +L      +G +LVR S S   DY LSL +    +H +I+R  +  
Sbjct: 2  RWYHGKISREVAEALLLREGGRDGLFLVRESTSAPGDYVLSLLAQGEVLHYQIRRHGE-D 60

Query: 69 KFILGQFSAPFDSVPEMIQHF 89
           F        F  +  +I+H+
Sbjct: 61 AFFSDDGPLIFHGLDTLIEHY 81


>gnl|CDD|198251 cd10388, SH2_SOCS7, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7). In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 48.1 bits (115), Expect = 1e-08
 Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 2/69 (2%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRD 64
          + L    WY G ++  +AE +L N  +GS+LVR+S  +R  +SLS +S     H +I  +
Sbjct: 5  RELKDCGWYWGPMSWEDAEKVLSNKPDGSFLVRDSSDDRYIFSLSFRSQGSVHHTRI--E 62

Query: 65 PDTGKFILG 73
             G F LG
Sbjct: 63 QYQGTFSLG 71


>gnl|CDD|198261 cd10398, SH2_Tec_Txk, Src homology 2 (SH2) domain found  in Tec
          protein, Txk.  A member of the Tec protein tyrosine
          kinase Txk is expressed in thymus, spleen, lymph node,
          T lymphocytes, NK cells, mast cell lines, and myeloid
          cell line. Txk plays a role in TCR signal transduction,
          T cell development, and selection which is analogous to
          the function of Itk. Txk has been shown to interact
          with IFN-gamma. Unlike most of the Tec family members
          Txk lacks a  PH domain. Instead Txk has a unique region
          containing a palmitoylated cysteine string which has a
          similar membrane tethering function as the PH domain.
          Txk also has a zinc-binding motif, a SH3 domain, a SH2
          domain, and a protein kinase catalytic domain. The TH
          domain consists of a Zn2+-binding Btk motif and a
          proline-rich region. The Btk motif is found in Tec
          kinases, Ras GAP, and IGBP and crucial to the function
          of the PH domain. It is not present in Txk which is not
          surprising since it lacks a PH domain. The type 1
          splice form of the Drosophila homolog also lacks both
          the PH domain and the Btk motif. The proline-rich
          regions are highly conserved for the most part with the
          exception of Bmx whose residues surrounding the PXXP
          motif are not conserved (TH-like) and Btk29A  which is
          entirely unique with large numbers of glycine residues
          (TH-extended).  Tec family members all lack a
          C-terminal tyrosine having an autoinhibitory function
          in its phosphorylated state. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 106

 Score = 47.6 bits (113), Expect = 2e-08
 Identities = 31/93 (33%), Positives = 58/93 (62%), Gaps = 10/93 (10%)

Query: 7  LDQRNWYHGSVTRHEAENILRN-SNEGSYLVRNSESNRPDYSLSLKS-ARGFM-----HM 59
          L+   WYH ++TR++AE +LR  S EG+++VR+S  +   Y++S+ + AR        H 
Sbjct: 3  LEIYEWYHKNITRNQAERLLRQESKEGAFIVRDS-RHLGSYTISVFTRARRSTEASIKHY 61

Query: 60 KIQRDPDTGKFILGQFSAPFDSVPEMIQHFAEN 92
          +I+++ D+G++ + +    F S+PE+IQ+   N
Sbjct: 62 QIKKN-DSGQWYVAERHL-FQSIPELIQYHQHN 92


>gnl|CDD|198282 cd10419, SH2_Src_Fyn_isoform_b_like, Src homology 2 (SH2) domain
          found in Fyn isoform b like proteins.  Fyn is a member
          of the Src non-receptor type tyrosine kinase family of
          proteins. This cd contains the SH2 domain found in Fyn
          isoform b type proteins. Fyn is involved in the control
          of cell growth and is required in the following
          pathways: T and B cell receptor signaling,
          integrin-mediated signaling, growth factor and cytokine
          receptor signaling, platelet activation, ion channel
          function, cell adhesion, axon guidance, fertilization,
          entry into mitosis, and differentiation of natural
          killer cells, oligodendrocytes and keratinocytes. The
          protein associates with the p85 subunit of
          phosphatidylinositol 3-kinase and interacts with the
          Fyn-binding protein. Alternatively spliced transcript
          variants encoding distinct isoforms exist. Fyn is
          primarily localized to the cytoplasmic leaflet of the
          plasma membrane. Tyrosine phosphorylation of target
          proteins by Fyn serves to either regulate target
          protein activity, and/or to generate a binding site on
          the target protein that recruits other signaling
          molecules. FYN has been shown to interact with a number
          of proteins including: BCAR1, Cbl, Janus kinase,
          nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome
          protein, and Zap-70. Fyn has a unique N-terminal
          domain, an SH3 domain, an SH2 domain, a kinase domain
          and a regulatory tail, as do the other members of the
          family. In general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 47.4 bits (112), Expect = 3e-08
 Identities = 27/89 (30%), Positives = 52/89 (58%), Gaps = 9/89 (10%)

Query: 10 RNWYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLK---SARG--FMHMKIQ 62
            WY G + R +AE  L +  +  G++L+R SE+ +  YSLS++     +G    H KI+
Sbjct: 3  EEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR 62

Query: 63 RDPDTGKFILGQFSAPFDSVPEMIQHFAE 91
          +  + G +I  +  A F+++ +++QH++E
Sbjct: 63 KLDNGGYYITTR--AQFETLQQLVQHYSE 89


>gnl|CDD|198247 cd10384, SH2_SOCS3, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7). In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 47.0 bits (112), Expect = 3e-08
 Identities = 25/89 (28%), Positives = 46/89 (51%), Gaps = 8/89 (8%)

Query: 7  LDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPD 66
          L +  +Y  +V+  EA  +L     G++L+R+S   R  ++LS+K+  G  +++IQ +  
Sbjct: 7  LQESGFYWSTVSGKEANLLLSAEPAGTFLIRDSSDQRHFFTLSVKTESGTKNLRIQCEG- 65

Query: 67 TGKFIL-----GQFSAP-FDSVPEMIQHF 89
           G F L          P FD V +++ H+
Sbjct: 66 -GSFSLQTDPRSTQPVPRFDCVLKLVHHY 93


>gnl|CDD|198223 cd10360, SH2_Srm, Src homology 2 (SH2) domain found in
          Src-related kinase lacking C-terminal regulatory
          tyrosine and N-terminal myristoylation sites (srm).
          Srm is a nonreceptor protein kinase that has two SH2
          domains, a SH3 domain, and a kinase domain with a
          tyrosine residue for autophosphorylation.  However it
          lacks an N-terminal glycine for myristoylation and a
          C-terminal tyrosine which suppresses kinase activity
          when phosphorylated.  Srm is most similar to members of
          the Tec family who other members include: Tec, Btk/Emb,
          and Itk/Tsk/Emt. However Srm differs in its N-terminal
          unique domain it being much smaller than in the Tec
          family and is closer to Src. Srm is thought to be a new
          family of nonreceptor tyrosine kinases that may be
          redundant in function. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 79

 Score = 46.5 bits (110), Expect = 4e-08
 Identities = 21/80 (26%), Positives = 43/80 (53%), Gaps = 4/80 (5%)

Query: 12 WYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          WY   ++R +A+ +L +  +  G++L+R SES+   YSLS+++     H +I   P    
Sbjct: 2  WYFSGISRTQAQQLLLSPPNEPGAFLIRPSESSLGGYSLSVRAQAKVCHYRICMAPSGSL 61

Query: 70 FILGQFSAPFDSVPEMIQHF 89
          ++  Q    F  + E++ ++
Sbjct: 62 YL--QKGRLFPGLEELLAYY 79


>gnl|CDD|198228 cd10365, SH2_Src_Src, Src homology 2 (SH2) domain found in
          tyrosine kinase sarcoma (Src).  Src is a member of the
          Src non-receptor type tyrosine kinase family of
          proteins. Src is thought to play a role in the
          regulation of embryonic development and cell growth.
          Members here include v-Src and c-Src. v-Src lacks the
          C-terminal inhibitory phosphorylation site and is
          therefore constitutively active as opposed to normal
          cellular src (c-Src) which is only activated under
          certain circumstances where it is required (e.g. growth
          factor signaling). v-Src is an oncogene whereas c-Src
          is a proto-oncogene. c-Src consists of three domains,
          an N-terminal SH3 domain, a central SH2 domain and a
          tyrosine kinase domain. The SH2 and SH3 domains work
          together in the auto-inhibition of the kinase domain.
          The phosphorylation of an inhibitory tyrosine near the
          c-terminus of the protein produces a binding site for
          the SH2 domain which then facilitates binding of the
          SH3 domain to a polyproline site within the linker
          between the SH2 domain and the kinase domain. Binding
          of the SH3 domain inactivates the enzyme. This allows
          for multiple mechanisms for c-Src activation:
          dephosphorylation of the C-terminal tyrosine by a
          protein tyrosine phosphatase, binding of the SH2 domain
          by a competitive phospho-tyrosine residue, or
          competitive binding of a polyproline binding site to
          the SH3 domain.  Unlike most other Src members Src
          lacks cysteine residues in the SH4 domain that undergo
          palmitylation. Serine and threonine phosphorylation
          sites have also been identified in the unique domains
          of Src and are believed to modulate protein-protein
          interactions or regulate catalytic activity.
          Alternatively spliced forms of Src, which contain 6- or
          11-amino acid insertions in the SH3 domain, are
          expressed in CNS neurons. c-Src has a unique N-terminal
          domain, an SH3 domain, an SH2 domain, a kinase domain
          and a regulatory tail, as do the other members of the
          family. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 47.0 bits (111), Expect = 5e-08
 Identities = 29/88 (32%), Positives = 52/88 (59%), Gaps = 9/88 (10%)

Query: 12 WYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSL---KSARGF--MHMKIQRD 64
          WY G +TR E+E +L N  +  G++LVR SE+ +  Y LS+    +A+G    H KI R 
Sbjct: 5  WYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKI-RK 63

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFAEN 92
           D+G F +      F+S+ +++ +++++
Sbjct: 64 LDSGGFYITS-RTQFNSLQQLVAYYSKH 90


>gnl|CDD|198213 cd10350, SH2_SH2D4A, Src homology 2 domain found in the SH2 domain
           containing protein 4A (SH2D4A).  SH2D4A contains a
           single SH2 domain. In general SH2 domains are involved
           in signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 46.5 bits (110), Expect = 7e-08
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 4/96 (4%)

Query: 12  WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
           W+HG +T  +A  +L ++  GS+L+R SE  +  Y+LS  S  G  H  I    D+  F 
Sbjct: 9   WFHGILTLKKANELLLSTMPGSFLIRVSEKIK-GYALSYLSEEGCKHFLIDASADSYSF- 66

Query: 72  LGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHP 107
           LG       ++ +++++  E  +  LG E   LL+P
Sbjct: 67  LGVDQLQHATLADLVEYHKEEPITSLGKE--LLLYP 100


>gnl|CDD|198259 cd10396, SH2_Tec_Itk, Src homology 2 (SH2) domain found in Tec
          protein, IL2-inducible T-cell kinase (Itk).  A member
          of the Tec protein tyrosine kinase Itk is expressed
          thymus, spleen, lymph node, T lymphocytes, NK and mast
          cells. It plays a role in T-cell proliferation and
          differentiation, analogous to Tec family kinases Txk.
          Itk  has been shown to interact with Fyn,
          Wiskott-Aldrich syndrome protein, KHDRBS1, PLCG1,
          Lymphocyte cytosolic protein 2, Linker of activated T
          cells, Karyopherin alpha 2, Grb2, and Peptidylprolyl
          isomerase A. Most of the Tec family members have a PH
          domain (Txk and the short (type 1) splice variant of
          Drosophila Btk29A are exceptions), a Tec homology (TH)
          domain, a SH3 domain, a SH2 domain, and a protein
          kinase catalytic domain. The TH domain consists of a
          Zn2+-binding Btk motif and a proline-rich region. The
          Btk motif is found in Tec kinases, Ras GAP, and IGBP.
          It is crucial for the function of Tec PH domains and
          it's lack of presence in Txk is not surprising since it
          lacks a PH domain. The type 1 splice form of the
          Drosophila homolog also lacks both the PH domain and
          the Btk motif. The proline-rich regions are highly
          conserved for the most part with the exception of Bmx
          whose residues surrounding the PXXP motif are not
          conserved (TH-like) and Btk29A  which is entirely
          unique with large numbers of glycine residues
          (TH-extended).  Tec family members all lack a
          C-terminal tyrosine having an autoinhibitory function
          in its phosphorylated state. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 108

 Score = 46.7 bits (111), Expect = 7e-08
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 7  LDQRNWYHGSVTRHEAENILRNSN-EGSYLVRNSESNRPDYSLSL------KSARGFMHM 59
          LDQ  WY+ ++ R +AE +LR+   EG ++VR+S S    Y++SL      +      H 
Sbjct: 3  LDQYEWYNKNINRSKAEKLLRDEGKEGGFMVRDS-SQPGLYTVSLYTKAGGEGNPCIRHY 61

Query: 60 KIQRDPDTGKFILGQFSAPFDSVPEMIQHFAEN 92
           I+   D+ K         F+S+PE+I++   N
Sbjct: 62 HIKETNDSPKKYYLAEKHVFNSIPELIEYHKHN 94


>gnl|CDD|198231 cd10368, SH2_Src_Fyn, Src homology 2 (SH2) domain found in Fyn.
          Fyn is a member of the Src non-receptor type tyrosine
          kinase family of proteins. Fyn is involved in the
          control of cell growth and is required in the following
          pathways: T and B cell receptor signaling,
          integrin-mediated signaling, growth factor and cytokine
          receptor signaling, platelet activation, ion channel
          function, cell adhesion, axon guidance, fertilization,
          entry into mitosis, and differentiation of natural
          killer cells, oligodendrocytes and keratinocytes. The
          protein associates with the p85 subunit of
          phosphatidylinositol 3-kinase and interacts with the
          Fyn-binding protein. Alternatively spliced transcript
          variants encoding distinct isoforms exist. Fyn is
          primarily localized to the cytoplasmic leaflet of the
          plasma membrane. Tyrosine phosphorylation of target
          proteins by Fyn serves to either regulate target
          protein activity, and/or to generate a binding site on
          the target protein that recruits other signaling
          molecules. FYN has been shown to interact with a number
          of proteins including: BCAR1, Cbl, Janus kinase,
          nephrin, Sky, tyrosine kinase, Wiskott-Aldrich syndrome
          protein, and Zap-70. Fyn has a unique N-terminal
          domain, an SH3 domain, an SH2 domain, a kinase domain
          and a regulatory tail, as do the other members of the
          family. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 46.2 bits (109), Expect = 7e-08
 Identities = 27/89 (30%), Positives = 52/89 (58%), Gaps = 9/89 (10%)

Query: 10 RNWYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLK---SARG--FMHMKIQ 62
            WY G + R +AE  L +  +  G++L+R SE+ +  YSLS++     +G    H KI+
Sbjct: 3  EEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR 62

Query: 63 RDPDTGKFILGQFSAPFDSVPEMIQHFAE 91
          +  + G +I  +  A F+++ +++QH++E
Sbjct: 63 KLDNGGYYITTR--AQFETLQQLVQHYSE 89


>gnl|CDD|199830 cd10349, SH2_SH2D2A_SH2D7, Src homology 2 domain found in the SH2
          domain containing protein 2A and 7 (SH2D2A and SH2D7). 
          SH2D2A and SH7 both contain a single SH2 domain. In
          general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 77

 Score = 45.6 bits (108), Expect = 7e-08
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          W+HG +TR EAE +L    +G YLVR SES    + LS +S     H  + +  D    +
Sbjct: 2  WFHGFITRREAERLLEPKPQGCYLVRFSES-AVTFVLSYRSRTCCRHFLLAQLRDGRHVV 60

Query: 72 LGQFSAPFDSVPEMIQHF 89
          LG+ SA    + +++ H+
Sbjct: 61 LGEDSA-HARLQDLLLHY 77


>gnl|CDD|198264 cd10401, SH2_C-SH2_Syk_like, C-terminal Src homology 2 (SH2)
          domain found in Spleen tyrosine kinase (Syk) proteins. 
          ZAP-70 and Syk comprise a family of hematopoietic cell
          specific protein tyrosine kinases (PTKs) that are
          required for antigen and antibody receptor function.
          ZAP-70 is expressed in T and natural killer (NK) cells 
          and Syk is expressed in B cells, mast cells,
          polymorphonuclear leukocytes, platelets, macrophages,
          and immature T cells. They are required for the proper
          development of T and B cells, immune receptors, and
          activating NK cells. They consist of two N-terminal Src
          homology 2 (SH2) domains and a C-terminal kinase domain
          separated from the SH2 domains by a linker or hinge
          region. Phosphorylation of both tyrosine residues
          within the Immunoreceptor Tyrosine-based Activation
          Motifs (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI])
          by the Src-family PTKs is required for efficient
          interaction of ZAP-70 and Syk with the receptor
          subunits and for receptor function. ZAP-70 forms two
          phosphotyrosine binding pockets, one of which is shared
          by both SH2 domains.  In Syk the two SH2 domains do not
          form such a phosphotyrosine-binding site.  The SH2
          domains here are believed to function independently. In
          addition, the two SH2 domains of Syk display
          flexibility in their relative orientation, allowing Syk
          to accommodate a greater variety of spacing sequences
          between the ITAM phosphotyrosines and singly
          phosphorylated non-classical ITAM ligands. This model
          contains the C-terminus SH2 domains of Syk. In general
          SH2 domains are involved in signal transduction.  They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 99

 Score = 46.0 bits (109), Expect = 9e-08
 Identities = 24/81 (29%), Positives = 45/81 (55%), Gaps = 5/81 (6%)

Query: 12 WYHGSVTRHEAENILRNS--NEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W+HG ++R E+E IL       G +L+R  ++N   Y+L L      +H +I +D  TGK
Sbjct: 5  WFHGKISREESEQILLIGSKTNGKFLIRERDNNGS-YALCLLHDGKVLHYRIDKD-KTGK 62

Query: 70 FILGQFSAPFDSVPEMIQHFA 90
            +      FD++ ++++H++
Sbjct: 63 LSIPD-GKKFDTLWQLVEHYS 82


>gnl|CDD|198197 cd09944, SH2_Grb7_family, Src homology 2 (SH2) domain found in the
           growth factor receptor bound, subclass 7 (Grb7)
           proteins.  The Grb family binds to the epidermal growth
           factor receptor (EGFR, erbB1) via their SH2 domains.
           There are 3 members of the Grb7 family of proteins:
           Grb7, Grb10, and Grb14. They are composed of an
           N-terminal Proline-rich domain, a Ras Associating-like
           (RA) domain, a Pleckstrin Homology (PH) domain, a
           phosphotyrosine interaction region (PIR, BPS) and a
           C-terminal SH2 domain. The SH2 domains of Grb7, Grb10
           and Grb14 preferentially bind to a different RTK. Grb7
           binds strongly to the erbB2 receptor, unlike Grb10 and
           Grb14 which bind weakly to it. Grb14 binds to Fibroblast
           Growth Factor Receptor (FGFR). Grb10 has been shown to
           interact with many different proteins, including the
           insulin and IGF1 receptors, platelet-derived growth
           factor (PDGF) receptor-beta, Ret, Kit, Raf1 and MEK1,
           and Nedd4.  Grb7 family proteins are phosphorylated on
           serine/threonine as well as tyrosine residues. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 108

 Score = 45.5 bits (108), Expect = 2e-07
 Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 8/102 (7%)

Query: 12  WYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLKSARGFMHMKI--QRDPDT 67
           W+HG ++R EA  ++R     +G +LVR S+SN   + LSLK  +   H +I    D   
Sbjct: 7   WFHGGISRDEAARLIRQQGLVDGVFLVRESQSNPGAFVLSLKHGQKIKHYQIIPIEDEGQ 66

Query: 68  GKFILGQFSAPFDSVPEMIQHFAENRLPILGAEHMCLLHPMI 109
             F L      F  + ++++ +  N     G+    L H   
Sbjct: 67  WYFTLDDGVTKFYDLLQLVEFYQLNA----GSLPTRLKHYCT 104


>gnl|CDD|198184 cd09930, SH2_cSH2_p85_like, C-terminal Src homology 2 (cSH2) domain
           found in p85.  Phosphoinositide 3-kinases (PI3Ks) are
           essential for cell growth, migration, and survival.
           p110, the catalytic subunit, is composed of an
           adaptor-binding domain, a Ras-binding domain, a C2
           domain, a helical domain, and a kinase domain.  The
           regulatory unit is called p85 and is composed of an SH3
           domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain,
           a inter SH2 (iSH2) domain, and C-terminal (cSH2) domain.
            There are 2 inhibitory interactions between p110alpha
           and p85 of P13K: 1) p85 nSH2 domain with the C2,
           helical, and kinase domains of p110alpha and 2) p85 iSH2
           domain with C2 domain of p110alpha. There are 3
           inhibitory interactions between p110beta and p85 of
           P13K: 1) p85 nSH2 domain with the C2, helical, and
           kinase domains of p110beta, 2) p85 iSH2 domain with C2
           domain of p110alpha, and 3) p85 cSH2 domain with the
           kinase domain of p110alpha. It is interesting to note
           that p110beta is oncogenic as a wild type protein while
           p110alpha lacks this ability. One explanation is the
           idea that the regulation of p110beta by p85 is unique
           because of the addition of inhibitory contacts from the
           cSH2 domain and the loss of contacts in the iSH2 domain.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 104

 Score = 45.5 bits (108), Expect = 2e-07
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 13/98 (13%)

Query: 7   LDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPD 66
            D+R W  G + R +AE +LR   +G++L+R S S +  Y+ S+       H  I +  +
Sbjct: 3   HDERTWLVGDINRTQAEELLRGKPDGTFLIRES-STQGCYACSVVCNGEVKHCVIYKT-E 60

Query: 67  TGKFILGQFSAPFD---SVPEMIQHFAENRLPILGAEH 101
           TG    G F+ P++   S+ E++ H+A N L     +H
Sbjct: 61  TG---YG-FAEPYNLYESLKELVLHYAHNSL----EQH 90


>gnl|CDD|198207 cd10344, SH2_SLAP, Src homology 2 domain found in Src-like
          adaptor proteins.  SLAP belongs to the subfamily of
          adapter proteins that negatively regulate cellular
          signaling initiated by tyrosine kinases. It has a
          myristylated N-terminus, SH3 and SH2 domains with high
          homology to Src family tyrosine kinases, and a unique
          C-terminal tail, which is important for c-Cbl binding.
          SLAP negatively regulates platelet-derived growth
          factor (PDGF)-induced mitogenesis in fibroblasts and
          regulates F-actin assembly for dorsal ruffles
          formation. c-Cbl mediated SLAP inhibition towards actin
          remodeling. Moreover, SLAP enhanced PDGF-induced c-Cbl
          phosphorylation by SFK. In contrast, SLAP mitogenic
          inhibition was not mediated by c-Cbl, but it rather
          involved a competitive mechanism with SFK for
          PDGF-receptor (PDGFR) association and mitogenic
          signaling. Accordingly, phosphorylation of the Src
          mitogenic substrates Stat3 and Shc were reduced by
          SLAP. Thus, we concluded that SLAP regulates PDGFR
          signaling by two independent mechanisms: a competitive
          mechanism for PDGF-induced Src mitogenic signaling and
          a non-competitive mechanism for dorsal ruffles
          formation mediated by c-Cbl. SLAP is a hematopoietic
          adaptor containing Src homology (SH)3 and SH2 motifs
          and a unique carboxy terminus. Unlike c-Src, SLAP lacks
          a tyrosine kinase domain. Unlike c-Src, SLAP does not
          impact resorptive function of mature osteoclasts but
          induces their early apoptosis. SLAP negatively
          regulates differentiation of osteoclasts and
          proliferation of their precursors. Conversely, SLAP
          decreases osteoclast death by inhibiting activation of
          caspase 3. In general SH2 domains are involved in
          signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 104

 Score = 45.2 bits (107), Expect = 2e-07
 Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 9/88 (10%)

Query: 12 WYHGSVTRHEAENILR--NSNEGSYLVRNSESNRPDYSLSLKSARGFM-----HMKIQRD 64
          W    ++R +AE +L    +  GS+L+R SE+ R  YSLS++           H +I R 
Sbjct: 12 WLFEGLSREKAEELLMLPGNQVGSFLIRESETRRGCYSLSVRHRGSQSRDSVKHYRIFRL 71

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFAEN 92
           +   +I  + +  F  + +M+ H++E+
Sbjct: 72 DNGWFYISPRLT--FQCLEDMVNHYSES 97


>gnl|CDD|198219 cd10356, SH2_ShkA_ShkC, Src homology 2 (SH2) domain found in SH2
          domain-bearing protein kinases A and C (ShkA and ShkC).
           SH2-bearing genes cloned from Dictyostelium include
          two transcription factors, STATa and STATc, and a
          signaling factor, SHK1 (shkA). A database search of the
          Dictyostelium discoideum genome revealed two additional
          putative STAT sequences, dd-STATb and dd-STATd, and
          four additional putative SHK genes, dd-SHK2 (shkB),
          dd-SHK3 (shkC), dd-SHK4 (shkD), and dd-SHK5 (shkE).
          This model contains members of shkA and shkC.  All of
          the SHK members are most closely related to the protein
          kinases found in plants.  However these kinases in
          plants are not conjugated to any SH2 or SH2-like
          sequences. Alignment data indicates that the SHK SH2
          domains carry some features of the STAT SH2 domains in
          Dictyostelium. When STATc's linker domain was used for
          a BLAST search, the sequence between the protein kinase
          domain and the SH2 domain (the linker) of SHK was
          recovered, suggesting a close relationship among these
          molecules within this region. SHK's linker domain is
          predicted to contain an alpha-helix which is indeed
          homologous to that of STAT. Based on the phylogenetic
          alignment, SH2 domains can be grouped into two
          categories, STAT-type and Src-type. SHK family members
          are in between, but are closer to the STAT-type which
          indicates a close relationship between SHK and STAT
          families in their SH2 domains and further supports the
          notion that SHKs linker-SH2 domain evolved from STAT or
          STATL (STAT-like Linker-SH2) domain found in plants. In
          SHK, STAT, and SPT6, the linker-SH2 domains all reside
          exclusively in the C-terminal regions. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 113

 Score = 45.3 bits (107), Expect = 2e-07
 Identities = 28/76 (36%), Positives = 43/76 (56%), Gaps = 5/76 (6%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFM-HMKIQRDPDTGKF 70
          W+HG ++  E+EN L    EG++LVR S S    Y++S  S  G + H +I R    GKF
Sbjct: 12 WFHGDISTSESENRLNGKPEGTFLVRFSTSEPGAYTISKVSKNGGISHQRIHR--PGGKF 69

Query: 71 ILGQFSAPFDSVPEMI 86
           +   ++ + SV E+I
Sbjct: 70 QVN--NSKYLSVKELI 83


>gnl|CDD|198199 cd09946, SH2_HSH2_like, Src homology 2 domain found in
          hematopoietic SH2 (HSH2) protein.  HSH2 is thought to
          function as an adapter protein involved in tyrosine
          kinase signaling. It may also be involved in regulating
          cytokine signaling and cytoskeletal reorganization in
          hematopoietic cells. HSH2 contains several putative
          protein-binding motifs, SH3-binding proline-rich
          regions, and phosphotyrosine sites, but lacks enzymatic
          motifs. HSH2 was found to interact with
          cytokine-regulated tyrosine kinase c-FES and an
          activated Cdc42-associated tyrosine kinase ACK1. HSH2
          binds c-FES through both its C-terminal region and its
          N-terminal region including the SH2 domain and binds
          ACK1 via its N-terminal proline-rich region. Both
          kinases bound and tyrosine-phosphorylated HSH2 in
          mammalian cells.  In general SH2 domains are involved
          in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 102

 Score = 44.5 bits (105), Expect = 3e-07
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 1/63 (1%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          W+HG+++R  AEN+L +   GS+L+R S S    Y+LS K+     H  ++   D    I
Sbjct: 9  WFHGAISREAAENMLESQPLGSFLIRVSHS-HVGYTLSYKAQSSCRHFMVKLLDDGTFMI 67

Query: 72 LGQ 74
           G+
Sbjct: 68 PGE 70


>gnl|CDD|198190 cd09937, SH2_csk_like, Src homology 2 (SH2) domain found in
          Carboxyl-Terminal Src Kinase (Csk).  Both the
          C-terminal Src kinase (CSK) and CSK-homologous kinase
          (CHK) are members of the CSK-family of protein tyrosine
          kinases. These proteins suppress activity of Src-family
          kinases (SFK) by selectively phosphorylating the
          conserved C-terminal tail regulatory tyrosine by a
          similar mechanism. CHK is also capable of inhibiting
          SFKs by a non-catalytic mechanism that involves binding
          of CHK to SFKs to form stable protein complexes. The
          unphosphorylated form of SFKs is inhibited by CSK and
          CHK by a two-step mechanism. The first step involves
          the formation of a complex of SFKs with CSK/CHK with
          the SFKs in the complex are inactive. The second step,
          involves the phosphorylation of the C-terminal tail
          tyrosine of SFKs, which then dissociates and adopt an
          inactive conformation. The structural basis of how the
          phosphorylated SFKs dissociate from CSK/CHK to adopt
          the inactive conformation is not known. The inactive
          conformation of SFKs is stabilized by two
          intramolecular inhibitory interactions: (a) the pYT:SH2
          interaction in which the phosphorylated C-terminal tail
          tyrosine (YT) binds to the SH2 domain, and (b) the
          linker:SH3 interaction of which the SH2-kinase domain
          linker binds to the SH3 domain. SFKs are activated by
          multiple mechanisms including binding of the ligands to
          the SH2 and SH3 domains to displace the two inhibitory
          intramolecular interactions, autophosphorylation, and
          dephosphorylation of YT. By selective phosphorylation
          and the non-catalytic inhibitory mechanism CSK and CHK
          are able to inhibit the active forms of SFKs. CSK and
          CHK are regulated by phosphorylation and inter-domain
          interactions. They both contain SH3, SH2, and kinase
          domains separated by the SH3-SH2 connector and SH2
          kinase linker, intervening segments separating the
          three domains. They lack a conserved tyrosine
          phosphorylation site in the kinase domain and the
          C-terminal tail regulatory tyrosine phosphorylation
          site. The CSK SH2 domain is crucial for stabilizing the
          kinase domain in the active conformation. A disulfide
          bond here regulates CSK kinase activity. The
          subcellular localization and activity of CSK are
          regulated by its SH2 domain. In general SH2 domains are
          involved in signal transduction.  They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 98

 Score = 44.2 bits (105), Expect = 4e-07
 Identities = 24/85 (28%), Positives = 49/85 (57%), Gaps = 7/85 (8%)

Query: 11 NWYHGSVTRHEAENILRNSNEGSYLVRNSESNRP-DYSLSLKSARGFMHMKI-QRDPDTG 68
           W+HG ++R EAE +L+   +G +LVR S +N P DY+L +       H ++  R+   G
Sbjct: 4  PWFHGKISREEAERLLQPPEDGLFLVRES-TNYPGDYTLCVSFEGKVEHYRVIYRN---G 59

Query: 69 KFILGQFSAPFDSVPEMIQHFAENR 93
          K  + +    F+++ ++++H+ ++ 
Sbjct: 60 KLTIDE-EEYFENLIQLVEHYTKDA 83


>gnl|CDD|198265 cd10402, SH2_C-SH2_Zap70, C-terminal Src homology 2 (SH2) domain
          found in Zeta-chain-associated protein kinase 70
          (ZAP-70).  ZAP-70 and Syk comprise a family of
          hematopoietic cell specific protein tyrosine kinases
          (PTKs) that are required for antigen and antibody
          receptor function. ZAP-70 is expressed in T and natural
          killer (NK) cells  and Syk is expressed in B cells,
          mast cells, polymorphonuclear leukocytes, platelets,
          macrophages, and immature T cells. They are required
          for the proper development of T and B cells, immune
          receptors, and activating NK cells. They consist of two
          N-terminal Src homology 2 (SH2) domains and a
          C-terminal kinase domain separated from the SH2 domains
          by a linker or hinge region. Phosphorylation of both
          tyrosine residues within the Immunoreceptor
          Tyrosine-based Activation Motifs (ITAM; consensus
          sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs
          is required for efficient interaction of ZAP-70 and Syk
          with the receptor subunits and for receptor function.
          ZAP-70 forms two phosphotyrosine binding pockets, one
          of which is shared by both SH2 domains.  In Syk the two
          SH2 domains do not form such a phosphotyrosine-binding
          site.  The SH2 domains here are believed to function
          independently. In addition, the two SH2 domains of Syk
          display flexibility in their relative orientation,
          allowing Syk to accommodate a greater variety of
          spacing sequences between the ITAM phosphotyrosines and
          singly phosphorylated non-classical ITAM ligands. This
          model contains the C-terminus SH2 domains of Zap70. In
          general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 105

 Score = 43.4 bits (102), Expect = 9e-07
 Identities = 24/80 (30%), Positives = 46/80 (57%), Gaps = 5/80 (6%)

Query: 12 WYHGSVTRHEAENILRNSNE--GSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          WYHGS+ R EAE  L +  +  G +L+R  + +   Y+LSL   +   H +I +D  +GK
Sbjct: 12 WYHGSIARDEAERRLYSGAQPDGKFLLRERKES-GTYALSLVYGKTVYHYRIDQD-KSGK 69

Query: 70 FILGQFSAPFDSVPEMIQHF 89
          + + +    FD++ +++++ 
Sbjct: 70 YSIPE-GTKFDTLWQLVEYL 88


>gnl|CDD|198206 cd10343, SH2_SHIP, Src homology 2 (SH2) domain found in
          SH2-containing inositol-5'-phosphatase (SHIP) and
          SLAM-associated protein (SAP).  The SH2-containing
          inositol-5'-phosphatase, SHIP (also called
          SHIP1/SHIP1a), is a hematopoietic-restricted
          phosphatidylinositide phosphatase that translocates to
          the plasma membrane after extracellular stimulation and
          hydrolyzes the phosphatidylinositol-3-kinase
          (PI3K)-generated second messenger PI-3,4,5-P3 (PIP3) to
          PI-3,4-P2. As a result, SHIP dampens down PIP3 mediated
          signaling and represses the proliferation,
          differentiation, survival, activation, and migration of
          hematopoietic cells.  PIP3 recruits lipid-binding
          pleckstrin homology(PH) domain-containing proteins to
          the inner wall of the plasma membrane and activates
          them. PH domain-containing downstream effectors include
          the survival/proliferation enhancing serine/threonine
          kinase, Akt (protein kinase B), the tyrosine kinase,
          Btk, the regulator of protein translation, S6K, and the
          Rac and cdc42 guanine nucleotide exchange factor, Vav.
          SHIP is believed to act  as a tumor suppressor during
          leukemogenesis and lymphomagenesis, and may play a role
          in activating the immune system to combat cancer. SHIP
          contains an N-terminal SH2 domain, a centrally located
          phosphatase domain that specifically hydrolyzes the
          5'-phosphate from PIP3, PI-4,5-P2  and
          inositol-1,3,4,5- tetrakisphosphate (IP4), a C2 domain,
          that is an allosteric activating site when bound by
          SHIP's enzymatic product, PI-3,4-P2; 2 NPXY motifs that
          bind proteins with a phosphotyrosine binding (Shc, Dok
          1, Dok 2) or an SH2 (p85a, SHIP2) domain; and a
          proline-rich domain consisting of four PxxP motifs that
          bind a subset of SH3-containing proteins including
          Grb2, Src, Lyn, Hck, Abl, PLCg1, and PIAS1. The SH2
          domain of SHIP binds to the tyrosine phosphorylated
          forms of Shc, SHP-2, Doks, Gabs, CD150,
          platelet-endothelial cell adhesion molecule, Cas,
          c-Cbl, immunoreceptor tyrosine-based inhibitory motifs
          (ITIMs), and immunoreceptor tyrosine-based activation
          motifs (ITAMs). The X-linked lymphoproliferative
          syndrome (XLP) gene encodes SAP (also called
          SH2D1A/DSHP) a protein that consists of a 5 residue
          N-terminus, a single SH2 domain, and a short 25 residue
          C-terminal tail.  XLP is characterized by an extreme
          sensitivity to Epstein-Barr virus.  Both T and natural
          killer (NK) cell dysfunctions have been seen in XLP
          patients. SAP binds the cytoplasmic tail of Signaling
          lymphocytic activation molecule (SLAM), 2B4, Ly-9, and
          CD84. SAP is believed to function as a signaling
          inhibitor, by blocking or regulating binding of other
          signaling proteins. SAP and the SAP-like protein EAT-2
          recognize the sequence motif TIpYXX(V/I), which is
          found in the cytoplasmic domains of a restricted number
          of T, B, and NK cell surface receptors and are proposed
          to be natural inhibitors or regulators of the
          physiological role of a small family of receptors on
          the surface of these cells. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 103

 Score = 43.6 bits (103), Expect = 9e-07
 Identities = 19/40 (47%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 12 WYHGSVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSL 50
          WYHG++TR +AE +L +   +GS+LVR+SES    Y+L +
Sbjct: 5  WYHGNITRSKAEELLSKAGKDGSFLVRDSESVSGAYALCV 44


>gnl|CDD|198180 cd09926, SH2_CRK_like, Src homology 2 domain found in
          cancer-related signaling adaptor protein CRK.  SH2
          domain in the CRK proteins.  CRKI (SH2-SH3) and CRKII
          (SH2-SH3-SH3) are splicing isoforms of the oncoprotein
          CRK.  CRKs regulate transcription and cytoskeletal
          reorganization for cell growth and motility by linking
          tyrosine kinases to small G proteins. The SH2 domain of
          CRK associates with tyrosine-phosphorylated receptors
          or components of focal adhesions, such as p130Cas and
          paxillin. CRK transmits signals to small G proteins
          through effectors that bind its SH3 domain, such as
          C3G, the guanine-nucleotide exchange factor (GEF) for
          Rap1 and R-Ras, and DOCK180, the GEF for Rac6. The
          binding of p130Cas to the CRK-C3G complex activates
          Rap1, leading to regulation of cell adhesion, and
          activates R-Ras, leading to JNK-mediated activation of
          cell proliferation, whereas the binding of CRK DOCK180
          induces Rac1-mediated activation of cellular migration.
          The activity of the different splicing isoforms varies
          greatly with CRKI displaying substantial transforming
          activity, CRKII less so, and phosphorylated CRKII with
          no biological activity whatsoever.  CRKII has a linker
          region with a phosphorylated Tyr and an additional
          C-terminal SH3 domain. The phosphorylated Tyr creates a
          binding site for its SH2 domain which disrupts the
          association between CRK and its SH2 target proteins.
          In general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 106

 Score = 43.6 bits (103), Expect = 9e-07
 Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 6/80 (7%)

Query: 8  DQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKI----QR 63
          D+ +WY G ++R EA+ +L+    G +LVR+S +   DY LS+       H  I    Q 
Sbjct: 5  DRSSWYFGPMSRQEAQELLQGQRHGVFLVRDSSTIPGDYVLSVSENSRVSHYIINSLGQP 64

Query: 64 DPDTGKFILGQFSAPFDSVP 83
           P+  ++ +G     FD +P
Sbjct: 65 APNQSRYRIGDQE--FDDLP 82


>gnl|CDD|198227 cd10364, SH2_Src_Lyn, Src homology 2 (SH2) domain found in Lyn.
          Lyn is a member of the Src non-receptor type tyrosine
          kinase family of proteins and is expressed in the
          hematopoietic cells, in neural tissues, liver, and
          adipose tissue. There are two alternatively spliced
          forms of Lyn.  Lyn plays an inhibitory role in myeloid
          lineage proliferation. Following engagement of the B
          cell receptors, Lyn undergoes rapid phosphorylation and
          activation, triggering a cascade of signaling events
          mediated by Lyn phosphorylation of tyrosine residues
          within the immunoreceptor tyrosine-based activation
          motifs (ITAM) of the receptor proteins, and subsequent
          recruitment and activation of other kinases including
          Syk, phospholipase C2 (PLC2) and phosphatidyl
          inositol-3 kinase. These kinases play critical roles in
          proliferation, Ca2+ mobilization and cell
          differentiation. Lyn plays an essential role in the
          transmission of inhibitory signals through
          phosphorylation of tyrosine residues within the
          immunoreceptor tyrosine-based inhibitory motifs (ITIM)
          in regulatory proteins such as CD22, PIR-B and FC
          RIIb1. Their ITIM phosphorylation subsequently leads to
          recruitment and activation of phosphatases such as
          SHIP-1 and SHP-1 which further down modulate signaling
          pathways, attenuate cell activation and can mediate
          tolerance. Lyn also plays a role in the insulin
          signaling pathway. Activated Lyn phosphorylates insulin
          receptor substrate 1 (IRS1) leading to an increase in
          translocation of Glut-4 to the cell membrane and
          increased glucose utilization. It is the primary Src
          family member involved in signaling downstream of the B
          cell receptor. Lyn plays an unusual, 2-fold role in B
          cell receptor signaling; it is essential for initiation
          of signaling but is also later involved in negative
          regulation of the signal. Lyn has a unique N-terminal
          domain, an SH3 domain, an SH2 domain, a kinase domain
          and a regulatory tail, as do the other members of the
          family. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 43.4 bits (102), Expect = 1e-06
 Identities = 24/85 (28%), Positives = 46/85 (54%), Gaps = 9/85 (10%)

Query: 12 WYHGSVTRHEAENIL--RNSNEGSYLVRNSESNRPDYSLSLK--SARG---FMHMKIQRD 64
          W+   +TR +AE  L    ++ G++L+R SE+ +  YSLS++    +      H KI+  
Sbjct: 5  WFFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSYSLSVRDYDPQHGDVIKHYKIRSL 64

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHF 89
           + G +I  + +  F  + +MI+H+
Sbjct: 65 DNGGYYISPRIT--FPCISDMIKHY 87


>gnl|CDD|198245 cd10382, SH2_SOCS1, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7).  In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 98

 Score = 43.1 bits (102), Expect = 1e-06
 Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 2/83 (2%)

Query: 7  LDQRNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPD 66
          LD   +Y G ++  EA   L+    G++L+R+S      ++LS+K A G + ++I     
Sbjct: 7  LDASGFYWGPLSVEEAHAKLKREPVGTFLIRDSRQKNCFFALSVKMASGPVSIRI--LFK 64

Query: 67 TGKFILGQFSAPFDSVPEMIQHF 89
           GKF L      FD + ++++H+
Sbjct: 65 AGKFSLDGSKESFDCLFKLLEHY 87


>gnl|CDD|198279 cd10416, SH2_SH2D2A, Src homology 2 domain found in the SH2
          domain containing protein 2A (SH2D2A).  SH2D2A contains
          a single SH2 domain. In general SH2 domains are
          involved in signal transduction.  They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 102

 Score = 43.1 bits (101), Expect = 1e-06
 Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 2/87 (2%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          W+HG +TR EAE +L    +G YLVR SES    + L+ +S     H  + +  D    +
Sbjct: 9  WFHGFITRREAERLLEPKPQGCYLVRFSES-AVTFVLTYRSRTCCRHFLLAQLRDGRHVV 67

Query: 72 LGQFSAPFDSVPEMIQHFAENRLPILG 98
          LG+ SA    + +++ H+  + L   G
Sbjct: 68 LGEDSA-HARLQDLLLHYTAHPLSPYG 93


>gnl|CDD|198226 cd10363, SH2_Src_HCK, Src homology 2 (SH2) domain found in HCK.
          HCK is a member of the Src non-receptor type tyrosine
          kinase family of proteins and is expressed in
          hemopoietic cells. HCK is proposed to couple the Fc
          receptor to the activation of the respiratory burst. It
          may also play a role in neutrophil migration and in the
          degranulation of neutrophils. It has two different
          translational starts that have different subcellular
          localization. HCK has been shown to interact with BCR
          gene,  ELMO1 Cbl gene, RAS p21 protein activator 1,
          RASA3, Granulocyte colony-stimulating factor receptor,
          ADAM15 and RAPGEF1.  Like the other members of the Src
          family the SH2 domain in addition to binding the
          target, also plays an autoinhibitory role by binding to
          its C-terminal tail.  In general SH2 domains are
          involved in signal transduction. HCK has a unique
          N-terminal domain, an SH3 domain, an SH2 domain, a
          kinase domain and a regulatory tail, as do the other
          members of the family. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 104

 Score = 43.0 bits (101), Expect = 2e-06
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 9/85 (10%)

Query: 12 WYHGSVTRHEAENILRNSNE--GSYLVRNSESNRPDYSLSLKSARG-----FMHMKIQRD 64
          W+   ++R +AE  L       GS+++R+SE+ +  YSLS++           H KI R 
Sbjct: 5  WFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPQHGDTVKHYKI-RT 63

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHF 89
           D G F +   S  F ++ E++ H+
Sbjct: 64 LDNGGFYISPRST-FSTLQELVDHY 87


>gnl|CDD|198216 cd10353, SH2_Nterm_RasGAP, N-terminal Src homology 2 (SH2) domain
          found in Ras GTPase-activating protein 1 (GAP).  RasGAP
          is part of the GAP1 family of GTPase-activating
          proteins. The protein is located in the cytoplasm and
          stimulates the GTPase activity of normal RAS p21, but
          not its oncogenic counterpart. Acting as a suppressor
          of RAS function, the protein enhances the weak
          intrinsic GTPase activity of RAS proteins resulting in
          RAS inactivation, thereby allowing control of cellular
          proliferation and differentiation. Mutations leading to
          changes in the binding sites of either protein are
          associated with basal cell carcinomas. Alternative
          splicing results in two isoforms. The shorter isoform
          which lacks the N-terminal hydrophobic region, has the
          same activity, and is expressed in placental tissues.
          In general the longer isoform contains 2 SH2 domains, a
          SH3 domain, a pleckstrin homology (PH) domain, and a
          calcium-dependent phospholipid-binding C2 domain. The
          C-terminus contains the catalytic domain of RasGap
          which catalyzes the activation of Ras by hydrolyzing
          GTP-bound active Ras into an inactive GDP-bound form of
          Ras. This model contains the N-terminal SH2 domain. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 103

 Score = 42.9 bits (101), Expect = 2e-06
 Identities = 21/54 (38%), Positives = 28/54 (51%), Gaps = 1/54 (1%)

Query: 9  QRNWYHGSVTRHEAENILRNSNE-GSYLVRNSESNRPDYSLSLKSARGFMHMKI 61
             WYHG + R  AE  LR + + GSYL+R S+     + LS  S  G  H +I
Sbjct: 18 TNQWYHGRLDRTIAEERLRQAGKLGSYLIRESDRRPGSFVLSFLSRTGVNHFRI 71


>gnl|CDD|198220 cd10357, SH2_ShkD_ShkE, Src homology 2 (SH2) domain found in SH2
          domain-bearing protein kinases D and E (ShkD and ShkE).
           SH2-bearing genes cloned from Dictyostelium include
          two transcription factors, STATa and STATc, and a
          signaling factor, SHK1 (shkA). A database search of the
          Dictyostelium discoideum genome revealed two additional
          putative STAT sequences, dd-STATb and dd-STATd, and
          four additional putative SHK genes, dd-SHK2 (shkB),
          dd-SHK3 (shkC), dd-SHK4 (shkD), and dd-SHK5 (shkE).
          This model contains members of shkD and shkE. All of
          the SHK members are most closely related to the protein
          kinases found in plants.  However these kinases in
          plants are not conjugated to any SH2 or SH2-like
          sequences. Alignment data indicates that the SHK SH2
          domains carry some features of the STAT SH2 domains in
          Dictyostelium. When STATc's linker domain was used for
          a BLAST search, the sequence between the protein kinase
          domain and the SH2 domain (the linker) of SHK was
          recovered, suggesting a close relationship among these
          molecules within this region. SHK's linker domain is
          predicted to contain an alpha-helix which is indeed
          homologous to that of STAT. Based on the phylogenetic
          alignment, SH2 domains can be grouped into two
          categories, STAT-type and Src-type. SHK family members
          are in between, but are closer to the STAT-type which
          indicates a close relationship between SHK and STAT
          families in their SH2 domains and further supports the
          notion that SHKs linker-SH2 domain evolved from STAT or
          STATL (STAT-like Linker-SH2) domain found in plants. In
          SHK, STAT, and SPT6, the linker-SH2 domains all reside
          exclusively in the C-terminal regions.  In general SH2
          domains are involved in signal transduction.  They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 87

 Score = 42.1 bits (99), Expect = 2e-06
 Identities = 21/58 (36%), Positives = 34/58 (58%), Gaps = 4/58 (6%)

Query: 10 RNWYHGSVTRHEAENILRNSNEGSYLVRNSESNRP---DYSLSLKSARGFMHMKIQRD 64
          ++W+HG ++R EAE  LR   EG++L+R S S  P    +++S K     +H +I R 
Sbjct: 10 KSWFHGDISRDEAEKRLRGRPEGTFLIRLS-STDPKKTPFTISKKKKSKPVHKRISRI 66


>gnl|CDD|198273 cd10410, SH2_SH2B1, Src homology 2 (SH2) domain found in SH2B
          adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B1 (SH2-B,
          PSM), like other members of the SH2B adapter protein
          family, contains a pleckstrin homology domain, at least
          one dimerization domain, and a C-terminal SH2 domain
          which binds to phosphorylated tyrosines in a variety of
          tyrosine kinases.  SH2B1 and SH2B2  function in
          signaling pathways found downstream of growth hormone
          receptor and receptor tyrosine kinases, including the
          insulin, insulin-like growth factor-I (IGF-I),
          platelet-derived growth factor (PDGF), nerve growth
          factor, hepatocyte growth factor, and fibroblast growth
          factor receptors. SH2B2beta, a new isoform of SH2B2, is
          an endogenous inhibitor of SH2B1 and/or SH2B2
          (SH2B2alpha), negatively regulating insulin signaling
          and/or JAK2-mediated cellular responses. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 97

 Score = 41.9 bits (98), Expect = 3e-06
 Identities = 25/98 (25%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRN---SNEGSYLVRNSESNRPDYSLSLKSARGFMHMKI 61
          +PL    W+HG ++R +A  ++      + G +LVR SE+ R +Y L+        H+++
Sbjct: 3  QPLSGYPWFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRL 62

Query: 62 QRDPDTGKFILGQFSAP---FDSVPEMIQHFAENRLPI 96
            + +      GQ       F S+ +M++HF  + +P+
Sbjct: 63 SLNEE------GQCRVQHLWFQSIFDMLEHFRVHPIPL 94


>gnl|CDD|199832 cd10417, SH2_SH2D7, Src homology 2 domain found in the SH2 domain
          containing protein 7 (SH2D7).  SH2D7 contains a single
          SH2 domain. In general SH2 domains are involved in
          signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 102

 Score = 41.8 bits (98), Expect = 5e-06
 Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 2/80 (2%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGKFI 71
          W+HG +TR + E +LR+   GS+L+R S+     Y LS + +    H  I +  +    I
Sbjct: 9  WFHGFITRKQTEQLLRDKALGSFLIRLSDR-ATGYILSYRGSDRCRHFVINQLRNRRYLI 67

Query: 72 LGQFSAPFDSVPEMIQHFAE 91
           G  S+   ++ E+++H+ E
Sbjct: 68 SGDTSS-HSTLAELVRHYQE 86


>gnl|CDD|198234 cd10371, SH2_Src_Blk, Src homology 2 (SH2) domain found in B
          lymphoid kinase (Blk).  Blk is a member of the Src
          non-receptor type tyrosine kinase family of proteins.
          Blk is expressed in the B-cells. Unlike most other Src
          members Blk lacks cysteine residues in the SH4 domain
          that undergo palmitylation. Blk is required for the
          development of IL-17-producing gamma-delta T cells.
          Furthermore, Blk is expressed in lymphoid precursors
          and, in this capacity, plays a role in regulating
          thymus cellularity during ontogeny. Blk has a unique
          N-terminal domain, an SH3 domain, an SH2 domain, a
          kinase domain and a regulatory tail, as do the other
          members of the family. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 100

 Score = 41.5 bits (97), Expect = 6e-06
 Identities = 28/86 (32%), Positives = 51/86 (59%), Gaps = 8/86 (9%)

Query: 12 WYHGSVTRHEAE-NILRNSNE-GSYLVRNSESNRPDYSLSLK--SARG--FMHMKIQRDP 65
          W+  +++R +AE  +L   N+ GS+L+R SESN+  +SLS+K  + +G    H KI R  
Sbjct: 5  WFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDVTTQGEVVKHYKI-RSL 63

Query: 66 DTGKFILGQFSAPFDSVPEMIQHFAE 91
          D G + +      F ++  ++QH+++
Sbjct: 64 DNGGYYISPRIT-FPTLQALVQHYSK 88


>gnl|CDD|198209 cd10346, SH2_SH2B_family, Src homology 2 (SH2) domain found in
          SH2B adapter protein family.  The SH2B adapter protein
          family  has 3 members:  SH2B1 (SH2-B, PSM), SH2B2
          (APS), and SH2B3 (Lnk). SH2B family members contain a
          pleckstrin homology domain, at least one dimerization
          domain, and a C-terminal SH2 domain which binds to
          phosphorylated tyrosines in a variety of tyrosine
          kinases.  SH2B1 and SH2B2  function in signaling
          pathways found downstream of growth hormone receptor
          and receptor tyrosine kinases, including the insulin,
          insulin-like growth factor-I (IGF-I), platelet-derived
          growth factor (PDGF), nerve growth factor, hepatocyte
          growth factor, and fibroblast growth factor receptors.
          SH2B2beta, a new isoform of SH2B2, is an endogenous
          inhibitor of SH2B1 and/or SH2B2 (SH2B2alpha),
          negatively regulating insulin signaling and/or
          JAK2-mediated cellular responses. SH2B3 negatively
          regulates lymphopoiesis and early hematopoiesis. The
          lnk-deficiency results in enhanced production of B
          cells, and expansion as well as enhanced function of
          hematopoietic stem cells (HSCs), demonstrating negative
          regulatory functions of Sh2b3/Lnk in cytokine
          signaling. Sh2b3/Lnk also functions in responses
          controlled by cell adhesion and in crosstalk between
          integrin- and cytokine-mediated signaling. In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 97

 Score = 40.9 bits (96), Expect = 9e-06
 Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 12/99 (12%)

Query: 4  PKPLDQRNWYHGSVTRHEAEN-ILRN--SNEGSYLVRNSESNRPDYSLSLKSARGFMHMK 60
             L +  W+HG+++R +A   +L +     G +LVR SE+ R ++ L+        H++
Sbjct: 2  TAELSEYPWFHGTLSRSDAAQLVLHSGADGHGVFLVRQSETRRGEFVLTFNFQGRAKHLR 61

Query: 61 IQRDPDTGKFILGQFSAP---FDSVPEMIQHFAENRLPI 96
          +  +        GQ       F S+ +M++HF +N +P+
Sbjct: 62 LTLNEK------GQCRVQHLWFPSIFDMLEHFRQNPIPL 94


>gnl|CDD|198260 cd10397, SH2_Tec_Btk, Src homology 2 (SH2) domain found  in Tec
          protein, Bruton's tyrosine kinase (Btk).  A member of
          the Tec protein tyrosine kinase Btk is expressed in
          bone marrow, spleen, all hematopoietic cells except T
          lymphocytes and plasma cells where it plays a  crucial
          role in B cell maturation and mast cell activation. Btk
          has been shown to interact with GNAQ, PLCG2, protein
          kinase D1, B-cell linker, SH3BP5, caveolin 1, ARID3A,
          and GTF2I. Most of the Tec family members have a PH
          domain (Txk and the short (type 1) splice variant of
          Drosophila Btk29A are exceptions), a Tec homology (TH)
          domain, a SH3 domain, a SH2 domain, and a protein
          kinase catalytic domain. Btk is implicated in the
          primary immunodeficiency disease X-linked
          agammaglobulinemia (Bruton's agammaglobulinemia).  The
          TH domain consists of a Zn2+-binding Btk motif and a
          proline-rich region. The Btk motif is found in Tec
          kinases, Ras GAP, and IGBP.  It is crucial for the
          function of Tec PH domains and it's lack of presence in
          Txk is not surprising since it lacks a PH domain. The
          type 1 splice form of the Drosophila homolog also lacks
          both the PH domain and the Btk motif.  The proline-rich
          regions are highly conserved for the most part with the
          exception of Bmx whose residues surrounding the PXXP
          motif are not conserved (TH-like) and Btk29A  which is
          entirely unique with large numbers of glycine residues
          (TH-extended). Tec family members all lack a C-terminal
          tyrosine having an autoinhibitory function in its
          phosphorylated state. Two tyrosine phosphorylation (pY)
          sites have been identified in Btk: one located in the
          activation loop of the catalytic domain which regulates
          the transition between open (active) and closed
          (inactive) states and the other in its SH3 domain.  In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 106

 Score = 40.6 bits (95), Expect = 1e-05
 Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 6  PLDQRNWYHGSVTRHEAENILRNSN-EGSYLVRNSESNRPDYSLSLKSARG------FMH 58
           L+   WY  ++TR +AE +L+    EG ++VR+S S    Y++S+ +           H
Sbjct: 2  SLEMYEWYSKNMTRSQAEQLLKQEGKEGGFIVRDS-SKAGKYTVSVFAKSAGDPQGVIRH 60

Query: 59 MKIQRDPDTGKFILGQFSAPFDSVPEMIQHFAEN 92
            +   P   ++ L +    F ++PE+I +   N
Sbjct: 61 YVVCSTP-QSQYYLAEKHL-FSTIPELINYHQHN 92


>gnl|CDD|198208 cd10345, SH2_C-SH2_Zap70_Syk_like, C-terminal Src homology 2
          (SH2) domain found in Zeta-chain-associated protein
          kinase 70 (ZAP-70) and Spleen tyrosine kinase (Syk)
          proteins.  ZAP-70 and Syk comprise a family of
          hematopoietic cell specific protein tyrosine kinases
          (PTKs) that are required for antigen and antibody
          receptor function. ZAP-70 is expressed in T and natural
          killer (NK) cells and Syk is expressed in B cells, mast
          cells, polymorphonuclear leukocytes, platelets,
          macrophages, and immature T cells. They are required
          for the proper development of T and B cells, immune
          receptors, and activating NK cells. They consist of two
          N-terminal Src homology 2 (SH2) domains and a
          C-terminal kinase domain separated from the SH2 domains
          by a linker or hinge region. Phosphorylation of both
          tyrosine residues within the Immunoreceptor
          Tyrosine-based Activation Motifs (ITAM; consensus
          sequence Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs
          is required for efficient interaction of ZAP-70 and Syk
          with the receptor subunits and for receptor function.
          ZAP-70 forms two phosphotyrosine binding pockets, one
          of which is shared by both SH2 domains. In Syk the two
          SH2 domains do not form such a phosphotyrosine-binding
          site. The SH2 domains here are believed to function
          independently. In addition, the two SH2 domains of Syk
          display flexibility in their relative orientation,
          allowing Syk to accommodate a greater variety of
          spacing sequences between the ITAM phosphotyrosines and
          singly phosphorylated non-classical ITAM ligands. This
          model contains the C-terminus SH2 domains of both Syk
          and Zap70. In general SH2 domains are involved in
          signal transduction.  They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 95

 Score = 39.7 bits (92), Expect = 2e-05
 Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 12 WYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W+HG ++R E+E I+       G +L+R +  N   Y+L L      +H +I +D  TGK
Sbjct: 2  WFHGKISREESEQIVLIGSKTNGKFLIR-ARDNNGSYALCLLHEGKVLHYRIDKD-KTGK 59

Query: 70 FILGQFSAPFDSVPEMIQHF 89
            + +    FD++ ++++H+
Sbjct: 60 LSIPE-GKKFDTLWQLVEHY 78


>gnl|CDD|198262 cd10399, SH2_Tec_Bmx, Src homology 2 (SH2) domain found  in Tec
          protein, Bmx.  A member of the Tec protein tyrosine
          kinase Bmx is expressed in the endothelium of large
          arteries, fetal endocardium, adult endocardium of the
          left ventricle, bone marrow, lung, testis,
          granulocytes, myeloid cell lines, and prostate cell
          lines. Bmx is involved in the regulation of Rho and
          serum response factor (SRF). Bmx has been shown to
          interact with PAK1, PTK2, PTPN21, and RUFY1. Most of
          the Tec family members have a PH domain (Txk and the
          short (type 1) splice variant of Drosophila Btk29A are
          exceptions), a Tec homology (TH) domain, a SH3 domain,
          a SH2 domain, and a protein kinase catalytic domain.
          The TH domain consists of a Zn2+-binding Btk motif and
          a proline-rich region. The Btk motif is found in Tec
          kinases, Ras GAP, and IGBP.  It is crucial for the
          function of Tec PH domains. It is not present in Txk
          and the type 1 splice form of the Drosophila homolog.
          The proline-rich regions are highly conserved for the
          most part with the exception of Bmx whose residues
          surrounding the PXXP motif are not conserved (TH-like)
          and Btk29A  which is entirely unique with large numbers
          of glycine residues (TH-extended). Tec family members
          all lack a C-terminal tyrosine having an autoinhibitory
          function in its phosphorylated state. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 106

 Score = 39.6 bits (92), Expect = 3e-05
 Identities = 28/95 (29%), Positives = 53/95 (55%), Gaps = 10/95 (10%)

Query: 5  KPLDQRNWYHGSVTRHEAENILRNS-NEGSYLVRNSESNRPDYSLSL-----KSARGFM- 57
          + LD  +W+ G+++R ++E +LR    EG+++VRNS S    Y++SL        +G + 
Sbjct: 1  ENLDAYDWFAGNISRSQSEQLLRQKGKEGAFMVRNS-SQVGMYTVSLFSKAVNDKKGTVK 59

Query: 58 HMKIQRDPDTGKFILGQFSAPFDSVPEMIQHFAEN 92
          H  +  + +  K  L + +  FDS+P++I +   N
Sbjct: 60 HYHVHTNAEN-KLYLAE-NYCFDSIPKLIHYHQHN 92


>gnl|CDD|198269 cd10406, SH2_Vav2, Src homology 2 (SH2) domain found in the Vav2
          proteins.  Proto-oncogene vav is a member of the Dbl
          family of guanine nucleotide exchange factors (GEF) for
          the Rho family of GTP binding proteins. All vavs are
          activated by tyrosine phosphorylation leading to their
          activation. There are three Vav mammalian family
          members: Vav1 which is expressed in the hematopoietic
          system, and Vav2 and Vav3 are more ubiquitously
          expressed. Vav2 is a GEF for RhoA, RhoB and RhoG and
          may activate Rac1 and Cdc42. Vav2 has been shown to
          interact with CD19 and Grb2. Alternatively spliced
          transcript variants encoding different isoforms have
          been found for Vav2. Vav proteins are involved in
          several processes that require cytoskeletal
          reorganization, such as the formation of the
          immunological synapse (IS), phagocytosis, platelet
          aggregation, spreading, and transformation. Vavs
          function as guanine nucleotide exchange factors (GEFs)
          for the Rho/Rac family of GTPases. Vav family members
          have several conserved motifs/domains including: a
          leucine-rich region, a leucine-zipper, a calponin
          homology (CH) domain, an acidic domain, a Dbl-homology
          (DH) domain, a pleckstrin homology (PH) domain, a
          cysteine-rich domain, 2 SH3 domains, a proline-rich
          region, and a SH2 domain.  Vavs are the only known Rho
          GEFs that have both the DH/PH motifs and SH2/SH3
          domains in the same protein. The leucine-rich
          helix-loop-helix (HLH) domain is thought to be involved
          in protein heterodimerization with other HLH proteins
          and it may function as a negative regulator by forming
          inactive heterodimers. The CH domain  is usually
          involved in the association with filamentous actin, but
          in Vav it controls NFAT stimulation, Ca2+ mobilization,
          and its transforming activity. Acidic domains are
          involved in protein-protein interactions and contain
          regulatory tyrosines. The DH domain is a GDP-GTP
          exchange factor on Rho/Rac GTPases. The PH domain in
          involved in interactions with GTP-binding proteins,
          lipids and/or phosphorylated serine/threonine residues.
          The SH3 domain is involved in localization of proteins
          to specific sites within the cell interacting with
          protein with proline-rich sequences. The SH2 domain
          mediates a high affinity interaction with tyrosine
          phosphorylated proteins. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 103

 Score = 39.3 bits (91), Expect = 3e-05
 Identities = 19/84 (22%), Positives = 48/84 (57%), Gaps = 5/84 (5%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMK-IQRDPDTGKF 70
          W+ G++ R + +N+L++   G+YL+R   +    +++S+K      H+K +++D     +
Sbjct: 7  WFAGNMERQQTDNLLKSHASGTYLIRERPAEAERFAISIKFNDEVKHIKVVEKD----NW 62

Query: 71 ILGQFSAPFDSVPEMIQHFAENRL 94
          I    +  F+S+ E+++++  + L
Sbjct: 63 IHITEAKKFESLLELVEYYQCHSL 86


>gnl|CDD|198278 cd10415, SH2_Grb10, Src homology 2 (SH2) domain found in the
          growth factor receptor bound, subclass 10 (Grb10)
          proteins.  The Grb family binds to the epidermal growth
          factor receptor (EGFR, erbB1) via their SH2 domains.
          Grb10 is part of the Grb7 family of proteins which also
          includes Grb7, and Grb14. They are composed of an
          N-terminal Proline-rich domain, a Ras Associating-like
          (RA) domain, a Pleckstrin Homology (PH) domain, a
          phosphotyrosine interaction region (PIR, BPS) and a
          C-terminal SH2 domain. The SH2 domains of Grb7, Grb10
          and Grb14 preferentially bind to a different RTK. Grb10
          has been shown to interact with many different
          proteins, including the insulin and IGF1 receptors,
          platelet-derived growth factor (PDGF) receptor-beta,
          Ret, Kit, Raf1 and MEK1, and Nedd4. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 108

 Score = 39.2 bits (91), Expect = 5e-05
 Identities = 21/88 (23%), Positives = 47/88 (53%), Gaps = 4/88 (4%)

Query: 10 RNWYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDT 67
          ++W+HG ++R E+  I++     +G +L+R+S+SN   + L+L   +   + +I    D 
Sbjct: 5  QHWFHGRISREESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCHHQKIKNFQILPCEDD 64

Query: 68 GK--FILGQFSAPFDSVPEMIQHFAENR 93
          G+  F L   +  F  + +++  +  N+
Sbjct: 65 GQTFFSLDDGNTKFSDLIQLVDFYQLNK 92


>gnl|CDD|198225 cd10362, SH2_Src_Lck, Src homology 2 (SH2) domain in lymphocyte
          cell kinase (Lck).  Lck is a member of the Src
          non-receptor type tyrosine kinase family of proteins.
          It is expressed in the brain, T-cells, and NK cells.
          The unique domain of Lck mediates its interaction with
          two T-cell surface molecules, CD4 and CD8. It
          associates with their cytoplasmic tails on CD4 T helper
          cells  and CD8 cytotoxic T cells to assist signaling
          from the T cell receptor (TCR) complex. When the T cell
          receptor is engaged by the specific antigen presented
          by MHC, Lck phosphorylase the intracellular chains of
          the CD3 and zeta-chains of the TCR complex, allowing
          ZAP-70 to bind them. Lck then phosphorylates and
          activates ZAP-70, which in turn phosphorylates Linker
          of Activated T cells (LAT), a transmembrane protein
          that serves as a docking site for proteins including:
          Shc-Grb2-SOS, PI3K, and phospholipase C (PLC). The
          tyrosine phosphorylation cascade culminates in the
          intracellular mobilization of a calcium ions and
          activation of important signaling cascades within the
          lymphocyte, including the Ras-MEK-ERK pathway, which
          goes on to activate certain transcription factors such
          as NFAT, NF-kappaB, and AP-1. These transcription
          factors regulate the production cytokines such as
          Interleukin-2 that promote long-term proliferation and
          differentiation of the activated lymphocytes.  The
          N-terminal tail of Lck is myristoylated and
          palmitoylated and it tethers the protein to the plasma
          membrane of the cell. Lck also contains a SH3 domain, a
          SH2 domain, and a C-terminal tyrosine kinase domain.
          Lck has 2 phosphorylation sites, the first an
          autophosphorylation site that is linked to activation
          of the protein and the second which is phosphorylated
          by Csk, which inhibits it. Lck is also inhibited by
          SHP-1 dephosphorylation and by Cbl ubiquitin ligase,
          which is part of the ubiquitin-mediated pathway. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 38.7 bits (90), Expect = 7e-05
 Identities = 23/86 (26%), Positives = 44/86 (51%), Gaps = 9/86 (10%)

Query: 12 WYHGSVTRHEAE--NILRNSNEGSYLVRNSESNRPDYSLSLK-----SARGFMHMKIQRD 64
          W+  +++R++AE   +   +  GS+L+R SE+    +SLS++           H KI R+
Sbjct: 5  WFFKNLSRNDAERQLLAPGNTHGSFLIRESETTAGSFSLSVRDFDQNQGEVVKHYKI-RN 63

Query: 65 PDTGKFILGQFSAPFDSVPEMIQHFA 90
           D G F +      F  + E+++H+ 
Sbjct: 64 LDNGGFYISP-RITFPGLHELVRHYT 88


>gnl|CDD|198181 cd09927, SH2_Tensin_like, Src homology 2 domain found in
          Tensin-like proteins.  SH2 domain found in Tensin-like
          proteins. The Tensins are a family of intracellular
          proteins that interact with receptor tyrosine kinases
          (RTKs), integrins, and actin. They are thought act as
          signaling bridges between the extracellular space and
          the cytoskeleton. There are four homologues: Tensin1,
          Tensin2 (TENC1, C1-TEN), Tensin3 and Tensin4 (cten),
          all of which contain a C-terminal tandem SH2-PTB domain
          pairing, as well as actin-binding regions that may
          localize them to focal adhesions. The isoforms of
          Tensin2 and Tensin3 contain N-terminal C1 domains,
          which are atypical and not expected to bind to phorbol
          esters. Tensins 1-3 contain a phosphatase (PTPase) and
          C2 domain pairing which resembles PTEN (phosphatase and
          tensin homologue deleted on chromosome 10) protein.
          PTEN is a lipid phosphatase that dephosphorylates
          phosphatidylinositol 3,4,5-trisphosphate
          (PtdIns(3,4,5)P3) to yield phosphatidylinositol
          4,5-bisphosphate (PtdIns(4,5)P2). As PtdIns(3,4,5)P3 is
          the product of phosphatidylinositol 3-kinase (PI3K)
          activity, PTEN is therefore a key negative regulator of
          the PI3K pathway. Because of their PTEN-like domains,
          the Tensins may also possess phosphoinositide-binding
          or phosphatase capabilities. However, only Tensin2 and
          Tensin3 have the potential to be phosphatases since
          only their PTPase domains contain a cysteine residue
          that is essential for catalytic activity. In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 116

 Score = 38.6 bits (90), Expect = 7e-05
 Identities = 14/43 (32%), Positives = 28/43 (65%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSAR 54
          WY  +++R +A  +L++   G++LVR+S + +  Y L++K A 
Sbjct: 5  WYKPNISRDQAIALLKDKPPGTFLVRDSTTYKGAYGLAVKVAT 47


>gnl|CDD|198221 cd10358, SH2_PTK6_Brk, Src homology 2 domain found in
          protein-tyrosine kinase-6 (PTK6) which is also known as
          breast tumor kinase (Brk).  Human protein-tyrosine
          kinase-6 (PTK6, also known as breast tumor kinase
          (Brk)) is a member of the non-receptor protein-tyrosine
          kinase family and is expressed in two-thirds of all
          breast tumors. PTK6 (9). PTK6 contains a SH3 domain, a
          SH2 domain, and catalytic domains. For the case of the
          non-receptor protein-tyrosine kinases, the SH2 domain
          is typically involved in negative regulation of kinase
          activity by binding to a phosphorylated tyrosine
          residue near to the C terminus. The C-terminal sequence
          of PTK6 (PTSpYENPT where pY is phosphotyrosine) is
          thought to be a self-ligand for the SH2 domain. The
          structure of the SH2 domain resembles other SH2 domains
          except for a centrally located four-stranded
          antiparallel beta-sheet (strands betaA, betaB, betaC,
          and betaD). There are also differences in the loop
          length which might be responsible for PTK6 ligand
          specificity. There are two possible means of regulation
          of PTK6: autoinhibitory with the phosphorylation of Tyr
          playing a role in its negative regulation and
          autophosphorylation at this site, though it has been
          shown that PTK6 might phosphorylate signal
          transduction-associated proteins Sam68 and signal
          transducing adaptor family member 2 (STAP/BKS) in vivo.
          In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 100

 Score = 38.2 bits (88), Expect = 9e-05
 Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 4/85 (4%)

Query: 12 WYHGSVTRHEAENILR--NSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W+ G ++R EA   L+   +  G++L+R SE    DY LS++  +   H KI R    G+
Sbjct: 4  WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRR-AGGR 62

Query: 70 FILGQFSAPFDSVPEMIQHFAENRL 94
            L + +  F S+PE++ +     L
Sbjct: 63 LHLNE-AVSFLSLPELVNYHRAQSL 86


>gnl|CDD|198270 cd10407, SH2_Vav3, Src homology 2 (SH2) domain found in the Vav3
          proteins.  Proto-oncogene vav is a member of the Dbl
          family of guanine nucleotide exchange factors (GEF) for
          the Rho family of GTP binding proteins. All vavs are
          activated by tyrosine phosphorylation leading to their
          activation. There are three Vav mammalian family
          members: Vav1 which is expressed in the hematopoietic
          system, and Vav2 and Vav3 are more ubiquitously
          expressed. Vav3 preferentially activates RhoA, RhoG
          and, to a lesser extent, Rac1.  Alternatively spliced
          transcript variants encoding different isoforms have
          been described for this gene.  VAV3 has been shown to
          interact with Grb2. Vav proteins are involved in
          several processes that require cytoskeletal
          reorganization, such as the formation of the
          immunological synapse (IS), phagocytosis, platelet
          aggregation, spreading, and transformation. Vavs
          function as guanine nucleotide exchange factors (GEFs)
          for the Rho/Rac family of GTPases. Vav family members
          have several conserved motifs/domains including: a
          leucine-rich region, a leucine-zipper, a calponin
          homology (CH) domain, an acidic domain, a Dbl-homology
          (DH) domain, a pleckstrin homology (PH) domain, a
          cysteine-rich domain, 2 SH3 domains,  a proline-rich
          region, and a SH2 domain. Vavs are the only known Rho
          GEFs that have both the DH/PH motifs and SH2/SH3
          domains in the same protein. The leucine-rich
          helix-loop-helix (HLH) domain is thought to be involved
          in protein heterodimerization with other HLH proteins
          and it may function as a negative regulator by forming
          inactive heterodimers. The CH domain  is usually
          involved in the association with filamentous actin, but
          in Vav it controls NFAT stimulation, Ca2+ mobilization,
          and its transforming activity. Acidic domains are
          involved in protein-protein interactions and contain
          regulatory tyrosines.  The DH domain is a GDP-GTP
          exchange factor on Rho/Rac GTPases. The PH domain in
          involved in interactions with GTP-binding proteins,
          lipids and/or phosphorylated serine/threonine residues.
           The SH3 domain is involved in localization of proteins
          to specific sites within the cell interacting with
          protein with proline-rich sequences. The SH2 domain
          mediates a high affinity interaction with tyrosine
          phosphorylated proteins. In general SH2 domains are
          involved in signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 103

 Score = 37.7 bits (87), Expect = 2e-04
 Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKI-QRDPDTGKF 70
          WY G++ R +AE  L N    +YLVR+      +Y++S+K      H+KI  RD   G F
Sbjct: 7  WYAGAMERLQAETELINRVNSTYLVRHRTKESGEYAISIKYNNEVKHIKILTRD---GFF 63

Query: 71 ILGQFSAPFDSVPEMIQHFAENRL 94
           + + +  F S+ E+++++  + L
Sbjct: 64 HIAE-NRKFKSLMELVEYYKHHSL 86


>gnl|CDD|198275 cd10412, SH2_SH2B3, Src homology 2 (SH2) domain found in SH2B
          adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B3 (Lnk),
          like other members of the SH2B adapter protein family,
          contains a pleckstrin homology domain, at least one
          dimerization domain, and a C-terminal SH2 domain which
          binds to phosphorylated tyrosines in a variety of
          tyrosine kinases.  SH2B3 negatively regulates
          lymphopoiesis and early hematopoiesis. The
          lnk-deficiency results in enhanced production of B
          cells, and expansion as well as enhanced function of
          hematopoietic stem cells (HSCs), demonstrating negative
          regulatory functions of Sh2b3/Lnk in cytokine
          signaling. Sh2b3/Lnk also functions in responses
          controlled by cell adhesion and in crosstalk between
          integrin- and cytokine-mediated signaling. In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 97

 Score = 36.8 bits (85), Expect = 3e-04
 Identities = 23/88 (26%), Positives = 45/88 (51%), Gaps = 6/88 (6%)

Query: 12 WYHGSVTRHEAENILRN---SNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTG 68
          W+HG ++R +A  +++       G +LVR SE+ R +Y L+        H+++    + G
Sbjct: 10 WFHGPISRVKAAQLVQLQGPDAHGVFLVRQSETRRGEYVLTFNFQGRAKHLRLSLT-ERG 68

Query: 69 KFILGQFSAPFDSVPEMIQHFAENRLPI 96
          +  +      F SV +M+ HF  + +P+
Sbjct: 69 QCRVQHLH--FPSVVDMLHHFQRSPIPL 94


>gnl|CDD|198263 cd10400, SH2_SAP1a, Src homology 2 (SH2) domain found in
          SLAM-associated protein (SAP) 1a.  The X-linked
          lymphoproliferative syndrome (XLP) gene encodes SAP
          (also called SH2D1A/DSHP) a protein that consists of a
          5 residue N-terminus, a single SH2 domain, and a short
          25 residue C-terminal tail. XLP is characterized by an
          extreme sensitivity to Epstein-Barr virus.  Both T and
          natural killer (NK) cell dysfunctions have been seen in
          XLP patients. SAP binds the cytoplasmic tail of
          Signaling lymphocytic activation molecule (SLAM), 2B4,
          Ly-9, and CD84. SAP is believed to function as a
          signaling inhibitor, by blocking or regulating binding
          of other signaling proteins. SAP and the SAP-like
          protein EAT-2 recognize the sequence motif TIpYXX[VI],
          which is found in the cytoplasmic domains of a
          restricted number of T, B, and NK cell surface
          receptors and are proposed to be natural inhibitors or
          regulators of the physiological role of a small family
          of receptors on the surface of these cells.  In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 103

 Score = 36.7 bits (85), Expect = 4e-04
 Identities = 14/30 (46%), Positives = 21/30 (70%), Gaps = 1/30 (3%)

Query: 13 YHGSVTRHEAENILRNSN-EGSYLVRNSES 41
          YHG ++R   E +L  +  +GSYL+R+SES
Sbjct: 6  YHGKISRETGEKLLLAAGLDGSYLLRDSES 35


>gnl|CDD|198277 cd10414, SH2_Grb14, Src homology 2 (SH2) domain found in the
          growth factor receptor bound, subclass 14 (Grb14)
          proteins.  The Grb family binds to the epidermal growth
          factor receptor (EGFR, erbB1) via their SH2 domains.
          Grb14 is part of the Grb7 family of proteins which also
          includes Grb7, and Grb14. They are composed of an
          N-terminal Proline-rich domain, a Ras Associating-like
          (RA) domain, a Pleckstrin Homology (PH) domain, a
          phosphotyrosine interaction region (PIR, BPS) and a
          C-terminal SH2 domain. The SH2 domains of Grb7, Grb10
          and Grb14 preferentially bind to a different RTK. Grb14
          binds to Fibroblast Growth Factor Receptor (FGFR) and
          weakly to the erbB2 receptor. In general SH2 domains
          are involved in signal transduction. They typically
          bind pTyr-containing ligands via two surface pockets, a
          pTyr and hydrophobic binding pocket, allowing proteins
          with SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 108

 Score = 36.4 bits (84), Expect = 4e-04
 Identities = 21/86 (24%), Positives = 43/86 (50%), Gaps = 4/86 (4%)

Query: 12 WYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTGK 69
          W+H  ++R EA+ ++      +G +LVR+S+SN   + LS+   +   H +I    D G+
Sbjct: 7  WFHHKISRDEAQRLIIQQGLVDGVFLVRDSQSNPRTFVLSMSHGQKIKHFQIIPVEDDGE 66

Query: 70 --FILGQFSAPFDSVPEMIQHFAENR 93
              L      F  + ++++ +  N+
Sbjct: 67 LFHTLDDGHTRFTDLIQLVEFYQLNK 92


>gnl|CDD|198175 cd09919, SH2_STAT_family, Src homology 2 (SH2) domain found in
          signal transducer and activator of transcription (STAT)
          family.  STAT proteins mediate the signaling of
          cytokines and a number of growth factors from the
          receptors of these extracellular signaling molecules to
          the cell nucleus.  STATs are specifically
          phosphorylated by receptor-associated Janus kinases,
          receptor tyrosine kinases, or cytoplasmic tyrosine
          kinases. The phosphorylated STAT molecules dimerize by
          reciprocal binding of their SH2 domains to the
          phosphotyrosine residues. These dimeric STATs
          translocate into the nucleus, bind to specific DNA
          sequences, and regulate the transcription of their
          target genes.  However there are a number of
          unphosphorylated STATs that travel between the
          cytoplasm and nucleus and some STATs that exist as
          dimers in unstimulated cells that can exert biological
          functions independent of being activated by a receptor.
          There are seven mammalian STAT family members which
          have been identified: STAT1, STAT2, STAT3, STAT4, STAT5
          (STAT5A and STAT5B), and STAT6. There are 6 conserved
          domains in STAT: N-terminal domain (NTD), coiled-coil
          domain (CCD), DNA-binding domain (DBD), alpha-helical
          linker domain (LD), SH2 domain, and transactivation
          domain (TAD).  NTD is involved in dimerization of
          unphosphorylated STATs monomers and for the
          tetramerization between STAT1, STAT3, STAT4 and STAT5
          on promoters with two or more tandem STAT binding
          sites.  It also plays a role in promoting interactions
          with transcriptional co-activators such as CREB binding
          protein (CBP)/p300, as well as being important for
          nuclear import and deactivation of STATs involving
          tyrosine de-phosphorylation. The CCD interacts with
          other proteins, such as IFN regulatory protein 9
          (IRF-9/p48) with STAT1 and c-JUN with STAT3 and is also
          thought to participate in the negative regulation of
          these proteins. Distinct genes are bound to STATs via
          their DBD domain. This domain is also involved in
          nuclear translocation of activated STAT1 and STAT3
          phosphorylated dimers upon cytokine stimulation.  LD
          links the DNA-binding and SH2 domains and is important
          for the transcriptional activation of STAT1 in response
          to IFN-gamma. It also plays a role in protein-protein
          interactions and has also been implicated in the
          constitutive nucleocytoplasmic shuttling of
          unphosphorylated STATs in resting cells.  The SH2
          domain is necessary for receptor association and
          tyrosine phosphodimer formation. Residues within this
          domain may be particularly important for some cellular
          functions mediated by the STATs as well as residues
          adjacent to this domain.  The TAD interacts with
          several proteins, namely minichromosome maintenance
          complex component 5 (MCM5), breast cancer 1 (BRCA1) and
          CBP/p300. TAD also contains a modulatory
          phosphorylation site that regulates STAT activity and
          is necessary for maximal transcription of a number of
          target genes. The conserved tyrosine residue present in
          the C-terminus is crucial for dimerization via
          interaction with the SH2 domain upon the interaction of
          the ligand with the receptor. STAT activation by
          tyrosine phosphorylation also determines nuclear import
          and retention, DNA binding to specific DNA elements in
          the promoters of responsive genes, and transcriptional
          activation of STAT dimers. In addition to the SH2
          domain there is a coiled-coil domain, a DNA binding
          domain, and a transactivation domain in the STAT
          proteins. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 115

 Score = 33.7 bits (78), Expect = 0.005
 Identities = 11/35 (31%), Positives = 20/35 (57%), Gaps = 4/35 (11%)

Query: 12 WYHGSVT----RHEAENILRNSNEGSYLVRNSESN 42
          W  G +     + EAE++L+    G++L+R S+S 
Sbjct: 17 WQDGLIMGFISKEEAEDLLKKKPPGTFLLRFSDSE 51


>gnl|CDD|198276 cd10413, SH2_Grb7, Src homology 2 (SH2) domain found in the
          growth factor receptor bound, subclass 7 (Grb7)
          proteins.  The Grb family binds to the epidermal growth
          factor receptor (EGFR, erbB1) via their SH2 domains.
          Grb7 is part of the Grb7 family of proteins which also
          includes Grb10, and Grb14. They are composed of an
          N-terminal Proline-rich domain, a Ras Associating-like
          (RA) domain, a Pleckstrin Homology (PH) domain, a
          phosphotyrosine interaction region (PIR, BPS) and a
          C-terminal SH2 domain. The SH2 domains of Grb7, Grb10
          and Grb14 preferentially bind to a different RTK. Grb7
          binds strongly to the erbB2 receptor, unlike Grb10 and
          Grb14 which bind weakly to it. Grb7 family proteins are
          phosphorylated on serine/threonine as well as tyrosine
          residues. In general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 108

 Score = 32.6 bits (74), Expect = 0.014
 Identities = 14/41 (34%), Positives = 25/41 (60%), Gaps = 2/41 (4%)

Query: 12 WYHGSVTRHEAENILRNSN--EGSYLVRNSESNRPDYSLSL 50
          W+HG ++R E++ ++      +G +LVR S+ N   + LSL
Sbjct: 7  WFHGRISREESQRLIGQQGLVDGVFLVRESQRNPQGFVLSL 47


>gnl|CDD|198249 cd10386, SH2_SOCS5, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) family.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7).  In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 81

 Score = 31.6 bits (71), Expect = 0.020
 Identities = 16/51 (31%), Positives = 30/51 (58%)

Query: 13 YHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQR 63
          Y G + R+EAE +L    EG++L+R+S      +S+S +     +H +I++
Sbjct: 3  YWGVMDRYEAEALLEGKPEGTFLLRDSAQEDYLFSVSFRRYNRSLHARIEQ 53


>gnl|CDD|198243 cd10380, SH2_Jak3, Src homology 2 (SH2) domain in the Janus
          kinase 3 (Jak3) proteins.  Jak3 is a member of the
          Janus kinase (JAK) family of tyrosine kinases involved
          in cytokine receptor-mediated intracellular signal
          transduction. It is predominantly expressed in immune
          cells and transduces a signal in response to its
          activation via tyrosine phosphorylation by interleukin
          receptors. Mutations in this gene are associated with
          autosomal SCID (severe combined immunodeficiency
          disease). In general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 96

 Score = 31.3 bits (71), Expect = 0.028
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 2  ANPKPL-DQRNWYHGSVTRHEAENILRN--SNEGSYLVRNSESNRPDYSLSLKSARGFMH 58
          A P+ L D  N  HG +T   A N L+   S  GS+++R S  +   + L++   +  + 
Sbjct: 3  APPRLLEDIENQCHGPITSEFAVNKLKKAGSEPGSFVLRRSPQDFDKFLLTV-CVQTTLG 61

Query: 59 MK-----IQRDPDTGKFILGQFSAPFDSVPEMIQHF 89
          +      I+++   G F L   S  F S+ E++  +
Sbjct: 62 LDYKDCLIRKNE--GHFSLAGVSRSFSSLKELLVTY 95


>gnl|CDD|198274 cd10411, SH2_SH2B2, Src homology 2 (SH2) domain found in SH2B
          adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B2 (APS),
          like other members of the SH2B adapter protein family,
          contains a pleckstrin homology domain, at least one
          dimerization domain, and a C-terminal SH2 domain which
          binds to phosphorylated tyrosines in a variety of
          tyrosine kinases. SH2B1 and SH2B2  function in
          signaling pathways found downstream of growth hormone
          receptor and receptor tyrosine kinases, including the
          insulin, insulin-like growth factor-I (IGF-I),
          platelet-derived growth factor (PDGF), nerve growth
          factor, hepatocyte growth factor, and fibroblast growth
          factor receptors. SH2B2beta, a new isoform of SH2B2, is
          an endogenous inhibitor of SH2B1 and/or SH2B2
          (SH2B2alpha), negatively regulating insulin signaling
          and/or JAK2-mediated cellular responses. In general SH2
          domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 97

 Score = 31.1 bits (70), Expect = 0.045
 Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 6/88 (6%)

Query: 12 WYHGSVTRHEAENILRNS---NEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQRDPDTG 68
          W+HG+++R +A  ++      + G +++R SE+   +Y L+        H+++  +   G
Sbjct: 10 WFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGEYVLTFNFQGKAKHLRLSLN-GHG 68

Query: 69 KFILGQFSAPFDSVPEMIQHFAENRLPI 96
          +  +      F SV +M++HF  + +P+
Sbjct: 69 QCHVQHLW--FQSVFDMLRHFHTHPIPL 94


>gnl|CDD|198205 cd10342, SH2_SAP1, Src homology 2 (SH2) domain found in
          SLAM-associated protein (SAP)1.  The X-linked
          lymphoproliferative syndrome (XLP) gene encodes SAP
          (also called SH2D1A/DSHP) a protein that consists of a
          5 residue N-terminus, a single SH2 domain, and a short
          25 residue C-terminal tail.  XLP is characterized by an
          extreme sensitivity to Epstein-Barr virus.  Both T and
          natural killer (NK) cell dysfunctions have been seen in
          XLP patients. SAP binds the cytoplasmic tail of
          Signaling lymphocytic activation molecule (SLAM), 2B4,
          Ly-9, and CD84. SAP is believed to function as a
          signaling inhibitor, by blocking or regulating binding
          of other signaling proteins. SAP and the SAP-like
          protein EAT-2 recognize the sequence motif TIpYXX[VI],
          which is found in the cytoplasmic domains of a
          restricted number of T, B, and NK cell surface
          receptors and are proposed to be natural inhibitors or
          regulators of the physiological role of a small family
          of receptors on the surface of these cells.  In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 103

 Score = 30.8 bits (69), Expect = 0.052
 Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 1/31 (3%)

Query: 12 WYHGSVTRHEAEN-ILRNSNEGSYLVRNSES 41
           YHG ++R   E  +L    +GSYL+R+SES
Sbjct: 5  VYHGKISRETGEKLLLATGLDGSYLLRDSES 35


>gnl|CDD|198248 cd10385, SH2_SOCS4, Src homology 2 (SH2) domain found in
          suppressor of cytokine signaling (SOCS) proteins.  SH2
          domain found in SOCS proteins. SOCS was first
          recognized as a group of cytokine-inducible SH2 (CIS)
          domain proteins comprising eight family members in
          human (CIS and SOCS1-SOCS7). In addition to the SH2
          domain, SOCS proteins have a variable N-terminal domain
          and a conserved SOCS box in the C-terminal domain. SOCS
          proteins bind to a substrate via their SH2 domain. The
          prototypical members, CIS and SOCS1-SOCS3, have been
          shown to regulate growth hormone signaling in vitro and
          in a classic negative feedback response compete for
          binding at phosphotyrosine sites in JAK kinase and
          receptor pathways to displace effector proteins and
          target bound receptors for proteasomal degradation.
          Loss of SOCS activity results in excessive cytokine
          signaling associated with a variety of hematopoietic,
          autoimmune, and inflammatory diseases and certain
          cancers. Members (SOCS4-SOCS7) were identified by their
          conserved SOCS box, an adapter motif of 3 helices that
          associates substrate binding domains, such as the SOCS
          SH2 domain, ankryin, and WD40 with ubiquitin ligase
          components. These show limited cytokine induction. In
          general SH2 domains are involved in signal
          transduction. They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 29.7 bits (66), Expect = 0.14
 Identities = 14/51 (27%), Positives = 29/51 (56%)

Query: 13 YHGSVTRHEAENILRNSNEGSYLVRNSESNRPDYSLSLKSARGFMHMKIQR 63
          Y G + ++ AE +L    EG++L+R+S      +S+S +     +H +I++
Sbjct: 13 YWGVMDKYAAEALLEGKPEGTFLLRDSAQEDYLFSVSFRRYSRSLHARIEQ 63


>gnl|CDD|171568 PRK12537, PRK12537, RNA polymerase sigma factor; Provisional.
          Length = 182

 Score = 30.1 bits (68), Expect = 0.18
 Identities = 12/26 (46%), Positives = 16/26 (61%), Gaps = 1/26 (3%)

Query: 10  RNWYHGSVTRHEAENILRNSNEGSYL 35
           R W + SVTRH A N+LR++     L
Sbjct: 76  RGWIY-SVTRHLALNVLRDTRREVVL 100


>gnl|CDD|198174 cd09918, SH2_Nterm_SPT6_like, N-terminal Src homology 2 (SH2)
          domain found in Spt6.  N-terminal SH2 domain in Spt6.
          Spt6 is an essential transcription elongation factor
          and histone chaperone that binds the C-terminal repeat
          domain (CTD) of RNA polymerase II. Spt6 contains a
          tandem SH2 domain with a novel structure and
          CTD-binding mode. The tandem SH2 domain binds to a
          serine 2-phosphorylated CTD peptide in vitro, whereas
          its N-terminal SH2 subdomain does not. CTD binding
          requires a positively charged crevice in the C-terminal
          SH2 subdomain, which lacks the canonical
          phospho-binding pocket of SH2 domains. The tandem SH2
          domain is apparently required for transcription
          elongation in vivo as its deletion in cells is lethal
          in the presence of 6-azauracil.  In general SH2 domains
          are involved in signal transduction.  They typically
          bind pTyr-containing ligands via two surface pockets, a
          pTyr and hydrophobic binding pocket, allowing proteins
          with SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 85

 Score = 28.7 bits (65), Expect = 0.22
 Identities = 16/56 (28%), Positives = 30/56 (53%), Gaps = 3/56 (5%)

Query: 21 EAENILRNSNEGSYLVRNSESNRPDY-SLSLKSARG-FMHMKIQRDPDTGKFILGQ 74
          +AE  L++ + G  ++R S S   D+ +++ K A G + H+ I+       F LG+
Sbjct: 12 QAEAYLKSKDVGEVVIRPS-SKGVDHLTVTWKVADGVYQHIDIEELNKENPFSLGK 66


>gnl|CDD|198201 cd10338, SH2_SHA, Src homology 2 (SH2) domain found in SH2
          adaptor proteins A (SHA) Signal transducers.  Signal
          transducing adaptor proteins are accessory to main
          proteins in a signal transduction pathway. These
          proteins lack intrinsic enzymatic activity, but mediate
          specific protein-protein interactions that drive the
          formation of protein complexes. Adaptor proteins
          usually contain several domains within their structure
          (e.g. SH2 and SH3 domains) which allow specific
          interactions with several other specific proteins. Not
          much is known about the SHA protein except that it is
          predicted to act as a transcription factor. Arabidopsis
          SHA pulled down a 120-kD tyrosine-phosphorylated
          protein in vitro. In addition to the SH2 domain there
          is a coiled-coil domain, a DNA binding domain, and a
          transactivation domain in the STAT proteins. In general
          SH2 domains are involved in signal transduction. They
          typically bind pTyr-containing ligands via two surface
          pockets, a pTyr and hydrophobic binding pocket,
          allowing proteins with SH2 domains to localize to
          tyrosine phosphorylated sites.
          Length = 106

 Score = 28.3 bits (63), Expect = 0.41
 Identities = 9/26 (34%), Positives = 16/26 (61%)

Query: 12 WYHGSVTRHEAENILRNSNEGSYLVR 37
          W  G +T+ EAE  L+    G++++R
Sbjct: 12 WIEGFITKEEAERSLQGQVPGTFILR 37


>gnl|CDD|215729 pfam00117, GATase, Glutamine amidotransferase class-I. 
          Length = 186

 Score = 28.8 bits (65), Expect = 0.50
 Identities = 17/49 (34%), Positives = 21/49 (42%), Gaps = 9/49 (18%)

Query: 67  TGKFILGQFSAPFDS--VPEMIQHFAENRLPILGAEHMCLLHPMIEQLL 113
            G  I     +P       E I+   EN++PILG    CL H    QLL
Sbjct: 42  DGIIISPGPGSPGALGGAIEAIKELRENKIPILGI---CLGH----QLL 83


>gnl|CDD|198177 cd09921, SH2_Jak_family, Src homology 2 (SH2) domain in the Janus
          kinase (Jak) family.  The Janus kinases (Jak) are a
          family of 4 non-receptor tyrosine kinases (Jak1, Jak2,
          Jak3, Tyk2) which respond to cytokine or growth factor
          receptor activation. To transduce cytokine signaling, a
          series of conformational changes occur in the
          receptor-Jak complex upon extracellular ligand binding.
          This results in trans-activation of the
          receptor-associated Jaks followed by phosphorylation of
          receptor tail tyrosine sites. The Signal Transducers
          and Activators of Transcription (STAT) are then
          recruited to the receptor tail, become phosphorylated
          and translocate to the nucleus to regulate
          transcription. Jaks have four domains: the pseudokinase
          domain, the catalytic tyrosine kinase domain, the FERM
          (band four-point-one, ezrin, radixin, and moesin)
          domain, and the SH2 (Src Homology-2) domain.  The Jak
          kinases are regulated by several enzymatic and
          non-enzymatic mechanisms. First, the Jak kinase domain
          is regulated by phosphorylation of the activation loop
          which is associated with the catalytically competent
          kinase conformation and is distinct from the inactive
          kinase conformation. Second, the pseudokinase domain
          directly modulates Jak catalytic activity with the FERM
          domain maintaining an active state. Third, the
          suppressor of cytokine signaling (SOCS) family and
          tyrosine phosphatases directly regulate Jak activity.
          Dysregulation of Jak activity can manifest as either a
          reduction or an increase in kinase activity resulting
          in immunodeficiency, inflammatory diseases,
          hematological defects, autoimmune and
          myeloproliferative disorders, and susceptibility to
          infection. Altered Jak regulation occurs by many
          mechanisms, including: gene translocations, somatic or
          inherited point mutations, receptor mutations, and
          alterations in the activity of Jak regulators such as
          SOCS or phosphatases.  In general SH2 domains are
          involved in signal transduction.  They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 97

 Score = 27.2 bits (61), Expect = 0.88
 Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 5/67 (7%)

Query: 27 RNSNEGSYLVRNSESNRPDYSLSL----KSARGFMHMKIQRDPDTGKFILGQFSAPFDSV 82
          R +  GSY++R SE+    Y + +     S       KI++  + G F L   S  + S+
Sbjct: 31 RGNKPGSYILRESETEYDTYYIDVCVKDGSRFQTKTFKIEKK-EGGVFFLDGDSREYPSL 89

Query: 83 PEMIQHF 89
           +++   
Sbjct: 90 RDLLNSL 96


>gnl|CDD|237139 PRK12564, PRK12564, carbamoyl phosphate synthase small subunit;
           Reviewed.
          Length = 360

 Score = 27.3 bits (62), Expect = 1.7
 Identities = 15/37 (40%), Positives = 19/37 (51%), Gaps = 7/37 (18%)

Query: 77  APFDSVPEMIQHFAENRLPILGAEHMCLLHPMIEQLL 113
           A  D   EMI+   E ++PI G   +CL H    QLL
Sbjct: 232 AALDYAIEMIRELLEKKIPIFG---ICLGH----QLL 261


>gnl|CDD|198235 cd10372, SH2_STAT1, Src homology 2 (SH2) domain found in signal
          transducer and activator of transcription (STAT) 1
          proteins.  STAT1 is a member of the STAT family of
          transcription factors. STAT1 is involved in
          upregulating genes due to a signal by interferons.
          STAT1 forms homodimers or heterodimers with STAT3 that
          bind to the Interferon-Gamma Activated Sequence (GAS)
          promoter element in response to IFN-gamma stimulation.
          STAT1 forms a heterodimer with STAT2 that can bind
          Interferon Stimulated Response Element (ISRE) promoter
          element in response to either IFN-alpha or IFN-beta
          stimulation. Binding in both cases leads to an
          increased expression of ISG (Interferon Stimulated
          Genes). STAT1 has been shown to interact with protein
          kinase R, Src, IRF1, STAT3, MCM5, STAT2, CD117, Fanconi
          anemia, complementation group C, CREB-binding protein,
          Interleukin 27 receptor, alpha subunit, PIAS1, BRCA1,
          Epidermal growth factor receptor, PTK2, Mammalian
          target of rapamycin, IFNAR2, PRKCD, TRADD, C-jun,
          Calcitriol receptor, ISGF3G, and GNB2L1. STAT proteins
          mediate the signaling of cytokines and a number of
          growth factors from the receptors of these
          extracellular signaling molecules to the cell nucleus. 
          STATs are specifically phosphorylated by
          receptor-associated Janus kinases, receptor tyrosine
          kinases, or cytoplasmic tyrosine kinases. The
          phosphorylated STAT molecules dimerize by reciprocal
          binding of their SH2 domains to the phosphotyrosine
          residues. These dimeric STATs translocate into the
          nucleus, bind to specific DNA sequences, and regulate
          the transcription of their target genes. However there
          are a number of unphosphorylated STATs that travel
          between the cytoplasm and nucleus and some STATs that
          exist as dimers in unstimulated cells that can exert
          biological functions independent of being activated.
          There are seven mammalian STAT family members which
          have been identified: STAT1, STAT2, STAT3, STAT4, STAT5
          (STAT5A and STAT5B), and STAT6. There are 6 conserved
          domains in STAT: N-terminal domain (NTD), coiled-coil
          domain (CCD), DNA-binding domain (DBD), alpha-helical
          linker domain (LD), SH2 domain, and transactivation
          domain (TAD). NTD is involved in dimerization of
          unphosphorylated STATs monomers and for the
          tetramerization between STAT1, STAT3, STAT4 and STAT5
          on promoters with two or more tandem STAT binding
          sites.  It also plays a role in promoting interactions
          with transcriptional co-activators such as CREB binding
          protein (CBP)/p300, as well as being important for
          nuclear import and deactivation of STATs involving
          tyrosine de-phosphorylation. CCD interacts with other
          proteins, such as IFN regulatory protein 9 (IRF-9/p48)
          with STAT1 and c-JUN with STAT3 and is also thought to
          participate in the negative regulation of these
          proteins. Distinct genes are bound to STATs via their
          DBD domain. This domain is also involved in nuclear
          translocation of activated STAT1 and STAT3
          phosphorylated dimers upon cytokine stimulation. LD
          links the DNA-binding and SH2  domains and is important
          for the transcriptional activation of STAT1 in response
          to IFN-gamma. It also plays a role in protein-protein
          interactions and has also been implicated in the
          constitutive nucleocytoplasmic shuttling of
          unphosphorylated STATs in resting cells.  The SH2
          domain is necessary for receptor association and
          tyrosine phosphodimer formation. Residues within this
          domain may be particularly important for some cellular
          functions mediated by the STATs as well as residues
          adjacent to this domain.  The TAD interacts with
          several proteins, namely minichromosome maintenance
          complex component 5 (MCM5), breast cancer 1 (BRCA1) and
          CBP/p300. TAD also contains a modulatory
          phosphorylation site that regulates STAT activity and
          is necessary for maximal transcription of a number of
          target genes. The conserved tyrosine residue present in
          the C-terminus is crucial for dimerization via
          interaction with the SH2 domain upon the interaction of
          the ligand with the receptor. STAT activation by
          tyrosine phosphorylation also determines nuclear import
          and retention, DNA binding to specific DNA elements in
          the promoters of responsive genes, and transcriptional
          activation of STAT dimers. In addition to the SH2
          domain there is a coiled-coil domain, a DNA binding
          domain, and a transactivation domain in the STAT
          proteins. In general SH2 domains are involved in signal
          transduction.  They typically bind pTyr-containing
          ligands via two surface pockets, a pTyr and hydrophobic
          binding pocket, allowing proteins with SH2 domains to
          localize to tyrosine phosphorylated sites.
          Length = 151

 Score = 26.8 bits (59), Expect = 1.9
 Identities = 9/29 (31%), Positives = 19/29 (65%)

Query: 15 GSVTRHEAENILRNSNEGSYLVRNSESNR 43
          G +++     +L++   G++L+R SES+R
Sbjct: 24 GFISKERERALLKDQQPGTFLLRFSESSR 52


>gnl|CDD|223579 COG0505, CarA, Carbamoylphosphate synthase small subunit [Amino
           acid transport and metabolism / Nucleotide transport and
           metabolism].
          Length = 368

 Score = 26.8 bits (60), Expect = 2.4
 Identities = 11/33 (33%), Positives = 17/33 (51%), Gaps = 3/33 (9%)

Query: 77  APFDSVPEMIQHFAENRLPILGAEHMCLLHPMI 109
           AP D   E I+     ++PI G   +CL H ++
Sbjct: 234 APLDYAIETIKELLGTKIPIFG---ICLGHQLL 263


>gnl|CDD|182125 PRK09870, PRK09870, tyrosine recombinase; Provisional.
          Length = 200

 Score = 26.4 bits (58), Expect = 3.2
 Identities = 12/38 (31%), Positives = 20/38 (52%), Gaps = 4/38 (10%)

Query: 1  MANPKPLDQRNWYHGSVTRHEAENILRNSNEGSYLVRN 38
          M N     +RN+    +T  E E++L+ +N G +  RN
Sbjct: 1  MKNKADNKKRNF----LTHSEIESLLKAANTGPHAARN 34


>gnl|CDD|235596 PRK05764, PRK05764, aspartate aminotransferase; Provisional.
          Length = 393

 Score = 26.6 bits (60), Expect = 3.3
 Identities = 9/19 (47%), Positives = 10/19 (52%)

Query: 75  FSAPFDSVPEMIQHFAENR 93
            + P D V EM Q F E R
Sbjct: 283 LNGPQDEVEEMRQAFEERR 301


>gnl|CDD|213346 cd12207, RasGAP_IQGAP3, Ras-GTPase Activating Domain of IQ motif
           containing GTPase activating protein 3.  This family
           represents the IQ motif containing GTPase activating
           protein 3 (IQGAP3), which associates with Ras
           GTP-binding proteins. A primary function of IQGAP
           proteins is to modulate cytoskeletal architecture. There
           are three known IQGAP family members: IQGAP1, IQGAP2 and
           IQGAP3. Human IQGAP1 and IQGAP2 share 62% identity.
           IQGAPs are multi-domain molecules having a
           calponin-homology (CH) domain which binds F-actin,
           IQGAP-specific repeats, a single WW domain, four IQ
           motifs that mediate interactions with calmodulin, and a
           RasGAP related domain that binds active Rho family
           GTPases. IQGAP is an essential regulator of cytoskeletal
           function. IQGAP1 negatively regulates Ras family GTPases
           by stimulating their intrinsic GTPase activity, the
           protein actually lacks GAP activity. Both IQGAP1 and
           IQGAP2 specifically bind to Cdc42 and Rac1, but not to
           RhoA. Despite of their similarities to part of the
           sequence of RasGAP, neither IQGAP1 nor IQGAP2 interacts
           with Ras. IQGAP3, only present in mammals, regulates the
           organization of the cytoskeleton under the regulation of
           Rac1 and Cdc42 in neuronal cells. The depletion of
           IQGAP3 is shown to impair neurite or axon outgrowth in
           neuronal cells with disorganized cytoskeleton.
          Length = 350

 Score = 26.3 bits (58), Expect = 3.4
 Identities = 10/31 (32%), Positives = 19/31 (61%)

Query: 81  SVPEMIQHFAENRLPILGAEHMCLLHPMIEQ 111
           SV +++QH A N+     +EH+  L+  +E+
Sbjct: 225 SVAKVLQHAAANKHFQGDSEHLQALNQYLEE 255


>gnl|CDD|219688 pfam07994, NAD_binding_5, Myo-inositol-1-phosphate synthase.  This
           is a family of myo-inositol-1-phosphate synthases.
           Inositol-1-phosphate catalyzes the conversion of
           glucose-6- phosphate to inositol-1-phosphate, which is
           then dephosphorylated to inositol. Inositol phosphates
           play an important role in signal transduction.
          Length = 389

 Score = 26.5 bits (59), Expect = 3.7
 Identities = 9/18 (50%), Positives = 11/18 (61%)

Query: 81  SVPEMIQHFAENRLPILG 98
           SVP +I+   E  LPI G
Sbjct: 199 SVPGLIELAEEKGLPIAG 216


>gnl|CDD|198266 cd10403, SH2_STAP1, Src homology 2 domain found in
          Signal-transducing adaptor protein 1 (STAP1).  STAP1 is
          a signal-transducing adaptor protein. It is composed of
          a Pleckstrin homology (PH) and SH2 domains along with
          several tyrosine phosphorylation sites. STAP-1 is an
          ortholog of BRDG1 (BCR downstream signaling 1). STAP1
          protein functions as a docking protein acting
          downstream of Tec tyrosine kinase in B cell antigen
          receptor signaling. The protein is phosphorylated by
          Tec and participates in a positive feedback loop,
          increasing Tec activity. STAP1 has been shown to
          interact with C19orf2, an unconventional prefoldin RPB5
          interactor. In general SH2 domains are involved in
          signal transduction. They typically bind
          pTyr-containing ligands via two surface pockets, a pTyr
          and hydrophobic binding pocket, allowing proteins with
          SH2 domains to localize to tyrosine phosphorylated
          sites.
          Length = 94

 Score = 25.1 bits (55), Expect = 5.8
 Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 6/80 (7%)

Query: 16 SVTRHEAENIL-RNSNEGSYLVRNSESNRPDYSLSLK---SARGFMHMKIQRDPDTGKFI 71
           V+R EAE +L RN + G+ L+R   S+  +YS++ +   +     H ++      G  I
Sbjct: 6  KVSRKEAEELLERNPSCGNMLLRPG-SDSSNYSITTRQEINKPRIKHYRVMSRGQ-GYTI 63

Query: 72 LGQFSAPFDSVPEMIQHFAE 91
            +      ++ ++I +F E
Sbjct: 64 ELEKPVTCPTLHDVINYFVE 83


>gnl|CDD|224180 COG1260, INO1, Myo-inositol-1-phosphate synthase [Lipid
           metabolism].
          Length = 362

 Score = 25.8 bits (57), Expect = 6.0
 Identities = 8/22 (36%), Positives = 10/22 (45%)

Query: 77  APFDSVPEMIQHFAENRLPILG 98
               S P  ++ F E  LPI G
Sbjct: 168 VFIASDPAWVELFEEKGLPIAG 189


>gnl|CDD|198239 cd10376, SH2_STAT5, Src homology 2 (SH2) domain found in signal
          transducer and activator of transcription (STAT) 5
          proteins.  STAT5 is a member of the STAT family of
          transcription factors.  Two highly related proteins,
          STAT5a and STAT5b are encoded by separate genes, but
          are 90% identical at the amino acid level.  Both STAT5a
          and STAT5b are ubiquitously expressed and  functionally
          interchangeable. Mice lacking either STAT5a or STAT5b
          have mild defects in prolactin dependent mammary
          differentiation or sexually dimorphic growth
          hormone-dependent effects, respectively. Mice lacking
          both STAT5a and STAT5b exhibit a perinatal lethal
          phenotype and have multiple defects, including anemia
          and a virtual absence of B and T lymphocytes. STAT
          proteins mediate the signaling of cytokines and a
          number of growth factors from the receptors of these
          extracellular signaling molecules to the cell nucleus. 
          STATs are specifically phosphorylated by
          receptor-associated Janus kinases, receptor tyrosine
          kinases, or cytoplasmic tyrosine kinases. The
          phosphorylated STAT molecules dimerize by reciprocal
          binding of their SH2 domains to the phosphotyrosine
          residues. These dimeric STATs translocate into the
          nucleus, bind to specific DNA sequences, and regulate
          the transcription of their target genes.  However there
          are a number of unphosphorylated STATs that travel
          between the cytoplasm and nucleus and some STATs that
          exist as dimers in unstimulated cells that can exert
          biological functions independent of being activated.
          There are seven mammalian STAT family members which
          have been identified: STAT1, STAT2, STAT3, STAT4, STAT5
          (STAT5A and STAT5B), and STAT6. There are 6 conserved
          domains in STAT: N-terminal domain (NTD), coiled-coil
          domain (CCD), DNA-binding domain (DBD), alpha-helical
          linker domain (LD), SH2 domain, and transactivation
          domain (TAD).  NTD is involved in dimerization of
          unphosphorylated STATs monomers and for the
          tetramerization between STAT1, STAT3, STAT4 and STAT5
          on promoters with two or more tandem STAT binding
          sites.  It also plays a role in promoting interactions
          with transcriptional co-activators such as CREB binding
          protein (CBP)/p300, as well as being important for
          nuclear import and deactivation of STATs involving
          tyrosine de-phosphorylation. CCD interacts with other
          proteins, such as IFN regulatory protein 9 (IRF-9/p48)
          with STAT1 and c-JUN with STAT3 and is also thought to
          participate in the negative regulation of these
          proteins. Distinct genes are bound to STATs via their
          DBD domain. This domain is also involved in nuclear
          translocation of activated STAT1 and STAT3
          phosphorylated dimers upon cytokine stimulation.  LD
          links the DNA-binding and SH2  domains and is important
          for the transcriptional activation of STAT1 in response
          to IFN-gamma. It also plays a role in protein-protein
          interactions and has also been implicated in the
          constitutive nucleocytoplasmic shuttling of
          unphosphorylated STATs in resting cells.  The SH2
          domain is necessary for receptor association and
          tyrosine phosphodimer formation. Residues within this
          domain may be particularly important for some cellular
          functions mediated by the STATs as well as residues
          adjacent to this domain.  The TAD interacts with
          several proteins, namely minichromosome maintenance
          complex component 5 (MCM5), breast cancer 1 (BRCA1) and
          CBP/p300. TAD also contains a modulatory
          phosphorylation site that regulates STAT activity and
          is necessary for maximal transcription of a number of
          target genes. The conserved tyrosine residue present in
          the C-terminus is crucial for dimerization via
          interaction with the SH2 domain upon the interaction of
          the ligand with the receptor. STAT activation by
          tyrosine phosphorylation also determines nuclear import
          and retention, DNA binding to specific DNA elements in
          the promoters of responsive genes, and transcriptional
          activation of STAT dimers. In addition to the SH2
          domain there is a coiled-coil domain, a DNA binding
          domain, and a transactivation domain in the STAT
          proteins.
          Length = 137

 Score = 24.9 bits (54), Expect = 8.0
 Identities = 10/27 (37%), Positives = 19/27 (70%)

Query: 15 GSVTRHEAENILRNSNEGSYLVRNSES 41
          G V + +A ++L N  +G++L+R S+S
Sbjct: 24 GFVNKQQAHDLLINKPDGTFLLRFSDS 50


>gnl|CDD|176239 cd08278, benzyl_alcohol_DH, Benzyl alcohol dehydrogenase.  Benzyl
           alcohol dehydrogenase is similar to liver alcohol
           dehydrogenase, but has some amino acid substitutions
           near  the active site, which may determine the enzyme's
           specificity of oxidizing aromatic substrates.  Also
           known as aryl-alcohol dehydrogenases, they catalyze the
           conversion of an aromatic alcohol + NAD+ to an aromatic
           aldehyde + NADH + H+.  NAD(P)(H)-dependent
           oxidoreductases are the major enzymes in the
           interconversion of alcohols and aldehydes, or ketones.
           Alcohol dehydrogenase in the liver converts ethanol and
           NAD+ to acetaldehyde and NADH, while in yeast and some
           other microorganisms ADH catalyzes the conversion
           acetaldehyde to ethanol in alcoholic fermentation.   ADH
           is a member of the medium chain alcohol dehydrogenase
           family (MDR), which has a NAD(P)(H)-binding domain in a
           Rossmann fold of a beta-alpha form.  The NAD(H)-binding
           region is comprised of 2 structurally similar halves,
           each of which contacts a mononucleotide.  A GxGxxG motif
           after the first mononucleotide contact half allows the
           close contact of the coenzyme with the ADH backbone.
           The N-terminal catalytic domain has a distant homology
           to GroES.  These proteins typically form dimers
           (typically higher plants, mammals) or tetramers (yeast,
           bacteria), and have 2 tightly bound zinc atoms per
           subunit, a catalytic zinc at the active site and a
           structural zinc in a lobe of the catalytic domain.
           NAD(H) binding occurs in the cleft between the catalytic
            and coenzyme-binding domains at the active site, and
           coenzyme binding induces a conformational closing of
           this cleft. Coenzyme binding typically precedes and
           contributes to substrate binding.  In human  ADH
           catalysis, the zinc ion helps coordinate the alcohol,
           followed by deprotonation of  a histidine, the ribose of
           NAD, a serine, then the alcohol, which allows the
           transfer of a hydride to NAD+, creating NADH and a
           zinc-bound aldehyde or ketone. In yeast and some
           bacteria, the active site zinc binds an aldehyde,
           polarizing it, and leading to the reverse reaction.
          Length = 365

 Score = 25.2 bits (56), Expect = 8.8
 Identities = 5/21 (23%), Positives = 12/21 (57%)

Query: 76  SAPFDSVPEMIQHFAENRLPI 96
           S P + +P +I+ + + + P 
Sbjct: 315 SVPQEFIPRLIELYRQGKFPF 335


>gnl|CDD|239880 cd04418, NDPk5, Nucleoside diphosphate kinase homolog 5 (NDP kinase
           homolog 5, NDPk5, NM23-H5; Inhibitor of p53-induced
           apoptosis-beta, IPIA-beta): In human, mRNA for NDPk5 is
           almost exclusively found in testis, especially in the
           flagella of spermatids and spermatozoa, in association
           with axoneme microtubules, and may play a role in
           spermatogenesis by increasing the ability of late-stage
           spermatids to eliminate reactive oxygen species.  It
           belongs to the nm23 Group II genes and appears to differ
           from the other human NDPks in that it lacks two
           important catalytic site residues, and thus does not
           appear to possess NDP kinase activity. NDPk5 confers
           protection from cell death by Bax and alters the
           cellular levels of several antioxidant enzymes,
           including glutathione peroxidase 5 (Gpx5).
          Length = 132

 Score = 24.7 bits (54), Expect = 9.5
 Identities = 9/20 (45%), Positives = 11/20 (55%)

Query: 8   DQRNWYHGSVTRHEAENILR 27
           D RN  HGS +   AE  +R
Sbjct: 109 DLRNAVHGSDSFSSAEREIR 128


>gnl|CDD|173827 cd00693, secretory_peroxidase, Horseradish peroxidase and related
           secretory plant peroxidases.  Secretory peroxidases
           belong to class III of the plant heme-dependent
           peroxidase superfamily. All members of the superfamily
           share a heme prosthetic group and catalyze a multistep
           oxidative reaction involving hydrogen peroxide as the
           electron acceptor. Class III peroxidases are found in
           the extracellular space or in the vacuole in plants
           where they have been implicated in hydrogen peroxide
           detoxification, auxin catabolism and lignin
           biosynthesis, and stress response. Class III peroxidases
           contain four conserved disulphide bridges and two
           conserved calcium binding sites.
          Length = 298

 Score = 25.2 bits (56), Expect = 9.9
 Identities = 8/18 (44%), Positives = 11/18 (61%)

Query: 77  APFDSVPEMIQHFAENRL 94
           +PF SV ++I  FA   L
Sbjct: 138 SPFFSVSQLISLFASKGL 155


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.319    0.135    0.408 

Gapped
Lambda     K      H
   0.267   0.0772    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 5,699,905
Number of extensions: 468907
Number of successful extensions: 578
Number of sequences better than 10.0: 1
Number of HSP's gapped: 511
Number of HSP's successfully gapped: 119
Length of query: 113
Length of database: 10,937,602
Length adjustment: 77
Effective length of query: 36
Effective length of database: 7,522,344
Effective search space: 270804384
Effective search space used: 270804384
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (24.1 bits)